Funded Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Initiative	Program Official
Abdi, Salahadin	University Of Tx Md Anderson Can Ctr United States	Innovative Treatment of Chemotherapy-Induced Painful Peripheral Neuropathy in Adolescents and Young Adults with Cancer: A two arm pilot study	5R21CA256136-02	PAR-20-292 (R21 Clinical Trial Optional)
Acciavatti, Raymond Joseph	University Of Pennsylvania United States	Next-Generation Tomosynthesis Pilot Study	5R37CA273959-03		Asad Umar, D.V.M., Ph.D.
Acharya, Munjal M	University Of California-Irvine United States	Stem cell-derived exosomes to ameliorate chemobrain	5R01CA262213-03	PAR-21-329 (R01 Clinical Trial Optional)	Rachel Altshuler, Ph.D.
Acoba, Jared	University Of Hawaii At Manoa United States	The Hawaii Minority/Underserved NCORP	5UG1CA189804-11		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Adams-Campbell, Lucile Lauren	Georgetown University United States	National Capital Area (NCA) Minority/Underserved NCORP	5UG1CA239758-06		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Adebamowo, Clement Adebayo	University Of Maryland Baltimore United States	Baltimore CASCADE Study Site (BaCSS Project)	5UG1CA284883-02		Maria Silvina Frech, Ph.D., M.S.
Afshar-Kharghan, Vahid	University Of Tx Md Anderson Can Ctr United States	Novel Biomarkers Predicting Blood Clots in Ovarian Cancer	5R01CA275762-02		Rachel Altshuler, Ph.D.
Agsalda-Garcia, Melissa Anne	University Of Hawaii At Manoa United States	Raman-enhanced spectroscopy (RESpect) for anal dysplasia in HIV-positive patients	1R21CA244078-01	PAR-18-020 (R21 Clinical Trial Optional)	Guillermo Marquez, Ph.D.
Ah, Diane Marie Von	Ohio State University United States	Cognitive Training for Cancer-related Cognitive Impairment: A Multi-Center Randomized Controlled Trial	5R01CA276222-03		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Ahn, Jiyoung	New York University School Of Medicine United States	The Oral Mycobiome and Risk of Pancreatic Cancer	5U01CA250186-04		Claire Zhu, Ph.D.
Ahn, Eun Hyun	Johns Hopkins University United States	Engineered biomimetic collective cancer invasion models for screening chemotherapeutic agents	5R01CA279948-02		Guillermo Marquez, Ph.D.
Alambeigi, Farshid	University Of Texas At Austin United States	A Novel Framework for Sensitive and Reliable Early Diagnosis, Topographic Mapping, and Stiffness Classification of Colorectal Cancer Polyps	5R21CA280747-02		Matthew Young, Ph.D.
Albertson, Donna G	New York University United States	Artemin overexpression in oral cancer pain and carcinogenesis	5R01CA228525-06		Rachel Altshuler, Ph.D.
Alexandrov, Ludmil B	University Of California, San Diego United States	Mapping immuno-genomic drivers of the head and neck precancer invasive-disease transition	5U01CA290479-02		Wendy Wang, Ph.D., M.Sc.
Allen, Peter J	Duke University United States	Preventing an Incurable Disease: The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)	5R01CA235677-05		Asad Umar, D.V.M., Ph.D.
Allen, Peter J	Duke University United States	Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas	5R01CA182076-07		Matthew Young, Ph.D.
Amuta, Ann Oyare	University Of Texas Arlington United States	Development of Tailored, Multilevel Cervical Cancer Interventions for Ethnically Diverse Black Women	1R15CA294297-01		Goli Samimi, Ph.D., M.P.H.
Anderson, Garnet L.	Fred Hutchinson Cancer Center United States	NCI Cancer Screening Research Network: Coordinating and Communication Center	3UG1CA286954-02S1		Elyse LeeVan, M.D., M.P.H.
Anderson, Daniel M	Healthpartners Institute United States	Metro-Minnesota Community Oncology Research Consortium (MMCORC)	5UG1CA189863-12		Vanessa A. White, M.P.H.
Anderson, Karen S.	Arizona State University-Tempe Campus United States	Southwest EDRN Clinical Validation Center for Head and Neck Cancer	5U01CA281660-02		Wendy Wang, Ph.D., M.Sc.
Armstrong, Gregory	St. Jude Children'S Research Hospital United States	Sen-Survivors: An open-label intervention trial for frailty and senescence	1U01CA246510-01		Eileen Dimond, R.N., M.S.
Arnold, Corey Wells	University Of California Los Angeles United States	Computational Feature Profiling and Modeling for Prostate Cancer Detection and Risk Stratification	5R01CA279666-02		Indu Kohaar, Ph.D., M.Phil., M.Sc.
Atigadda, Venkatram Reddy	University Of Alabama At Birmingham United States	Development of Potent and non-toxic rexinoids to prevent non-melanoma skin cancer	5R01CA276683-03
Azizoddin, Desiree R	Dana-Farber Cancer Inst United States	Leveraging mHealth to deliver integrated pain-CBT, opioid monitoring, and self-management support for advanced cancer patients coping with chronic pain	7R21CA263838-03		Brennan Streck, Ph.D., RN, M.P.H.
Backman, Vadim	Northwestern University At Chicago United States	Optical hyperspectral nanoscale chromatin analysis for colon cancer risk-stratification	1R01CA289294-01A1		Claire Zhu, Ph.D.
Badu-Tawiah, Abraham	Ohio State University United States	Multiplexed Paper-Based Blood Test for Early-Stage Colorectal Cancer Screening	5R21CA270727-02	PAR-20-292 (R21 Clinical Trial Optional)	Claire Zhu, Ph.D.
Badve, Sunil S.	Emory University United States	Early prediction of lethal phenotypes in triple negative breast cancer using multiscale, multi-modality platforms	5R01CA281932-02		Wendy Wang, Ph.D., M.Sc.
Bae-Jump, Victoria Lin	Univ Of North Carolina Chapel Hill United States	Obesity-driven Metabolic and Molecular Biomarkers of Metformin Response in Endometrial Cancer	5R37CA226969-07		Goli Samimi, Ph.D., M.P.H.
Baghdadi, Tareq Al	Saint Joseph Mercy Health System United States	Michigan Cancer Research Consortium NCORP	5UG1CA189971-11		Vanessa A. White, M.P.H.
Balu, Mihaela	University Of California-Irvine United States	Fast, large area, multiphoton exoscope (FLAME) for improving early detection of melanoma	5R01CA259019-03	PAR-20-155 (R01 Clinical Trial Optional)	Richard Mazurchuk, Ph.D.
Banerjee, Imon	Mayo Clinic Arizona United States	Multimodal AI Fusion Model for Early Detection for Pancreatic Cancer	1R01CA289249-01		Nick Hodges, Ph.D.
Bao, Ting	Dana-Farber Cancer Inst United States	Acupuncture for Chemothrapy-induced Peripheral Neuropathy Treatment (ACT) Trial	5R37CA248563-05		Asad Umar, D.V.M., Ph.D.
Bao, Ting	Dana-Farber Cancer Inst United States	Yoga for Chemotherapy-induced Peripheral Neuropathy Treatment (YCT) Trial	5R01CA251470-06		Goli Samimi, Ph.D., M.P.H.
Barber, Glen N.	University Of Miami School Of Medicine United States	Development of A HTLV-1 Vaccine	5R01CA252049-04	PA-20-185 (Parent R01 Clinical Trial Not Allowed)	Marjorie Perloff, M.D.
Barroilhet, Lisa M	University Of Wisconsin-Madison United States	Repurposing Atovaquone for Preventing Ovarian Cancer: An Example of Successful Inhibition of Oxidative Phosphorylation	5R01CA238423-05		Goli Samimi, Ph.D., M.P.H.
Barroilhet, Lisa M	University Of Wisconsin-Madison United States	The MW Cancer Prevention Clinical Trials Network	5UG1CA242635-05		Donald Johnsey
Bartolini, Francesca	Columbia University Health Sciences United States	Investigating the Pathogenic Role of Tubulin Post-translational Modifications in CIPN	1R01CA279401-01A1		Rachel Altshuler, Ph.D.
Barton, Jennifer Kehlet	University Of Arizona United States	Ovarian Cancer Detection with Blood- and Imaging-Based Biomarkers	5R01CA260399-04		Guillermo Marquez, Ph.D.
Bast, Robert C	University Of Tx Md Anderson Can Ctr United States	MD Anderson Cancer Center EDRN- Clinical Validation Center for Early Detection of Ovarian Cancer with a multiple marker algorithm	5U01CA200462-07		Christos Patriotis, Ph.D., M.Sc.
Basu, Partha	International Agency For Res On Cancer United States	A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICs	5R37CA275824-02		Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Beretta, Laura	University Of Tx Md Anderson Can Ctr United States	Early Detection of Hepatocellular Carcinoma	5R01CA195524-09		Matthew Young, Ph.D.
Bergan, Raymond C.	University Of Nebraska Medical Center United States	Regulation of extracellular proteases in prostate cancer progression to a metastatic phenotype	3R01CA276846-02S1		John Clifford, Ph.D.
Bertozzi, Carolyn	Stanford University United States	Chemical Glycoproteomics	5R01CA200423-22		Guillermo Marquez, Ph.D.
Bettegowda, Chetan	Johns Hopkins University United States	Interrogating malignant gliomas using released tumor DNA in cerebrospinal fluid	5R37CA230400-07		Sidney Fu, M.D.
Bhatt, Vijaya Raj	University Of Nebraska Medical Center United States	Aging trajectories and outcomes of older adults with acute myeloid leukemia	5R37CA276928-02		Brennan Streck, Ph.D., RN, M.P.H.
Bissonnette, Bruce Marc	University Of Chicago United States	A non-invasive blood test for multi-cancer detection and determination of tissue of origin preceding overt cancer diagnosis	1U01CA297685-01		Claire Zhu, Ph.D.
Blanke, Charles D.	Oregon Health & Science University United States	SWOG NCORP Research Base	5UG1CA189974-11		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Boone, Anna	University Of Missouri-Columbia United States	Pilot testing of metacognitive strategy training to address cancer-related cognitive impairment in breast cancer	1R21CA286404-01A1		Marjorie Perloff, M.D.
Borges, Chad R	Arizona State University-Tempe Campus United States	Plate reader assays to forensically assess exposure of plasma and serum to thawed conditions	5R21CA269091-03	RFA-CA-21-005 (R21 Clinical Trial Not Allowed)	Indu Kohaar, Ph.D., M.Phil., M.Sc.
Boutros, Paul Christopher	University Of California Los Angeles United States	Germline Determinants of Prostate Cancer Evolution	5R01CA270108-03		Guillermo Marquez, Ph.D.
Bower, Julienne E	University Of California Los Angeles United States	Mindfulness Meditation for Younger Breast Cancer Survivors: Testing Digital Interventions in Clinical and Community Settings	5R01CA282416-02		Brennan Streck, Ph.D., RN, M.P.H.
Boyer, Thomas G	University Of Texas Hlth Science Center United States	Pathological reprogramming of the m6A epitranscriptome in uterine fibroids	5R01HD106285-05		Goli Samimi, Ph.D., M.P.H.
Brand, Randall	University Of Pittsburgh At Pittsburgh United States	Validation of biomarkers for risk prediction and early diagnosis of Pancreatic Adenocarcinoma	5U01CA200466-08		Matthew Young, Ph.D.
Bresalier, Robert S	University Of Tx Md Anderson Can Ctr United States	Great Lakes New England Clinical Validation Center	5U01CA086400-23		Matthew Young, Ph.D.
Brown, Austin L	Baylor College Of Medicine United States	A Systems Epidemiology Approach for Predicting Methotrexate Neurotoxicity in Pediatric Acute Leukemia	5R01CA272981-03		Rachel Altshuler, Ph.D.
Bruner, Deborah Watkins	Nrg Oncology Foundation, Inc. United States	NRG Oncology NCORP Research Base	5UG1CA189867-11		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Bryan, Angela	University Of Colorado United States	Cannabis for Palliative Care in Cancer: A Placebo-controlled Randomized Trial of Full Spectrum Hemp-derived CBD/THC	5R01CA284860-02		Brennan Streck, Ph.D., RN, M.P.H.
Buczynski, Matthew Wallace	Virginia Polytechnic Inst And St Univ United States	Anti-nociceptive actions of CART II in chemotherapy-induced peripheral neuropathy	5R01CA284075-03		Rachel Altshuler, Ph.D.
Burgess, Mark Thomas	Sloan-Kettering Inst Can Research United States	Clinical assessment of radiotherapy-induced vaginal toxicity with multiparametric ultrasound imaging	1R21CA290252-01		Goli Samimi, Ph.D., M.P.H.
Buszczak, Michael	Ut Southwestern Medical Center United States	Developing ribosome biogenesis inhibitors for the prevention of cancer	5UG3CA290312-02		Kajal Biswas, Ph.D.
Butryn, Meghan	Drexel University United States	Efficacy of a multi-level intervention designed to promote adherence to WCRF/AICR dietary guidelines for cancer prevention	1R01CA288323-01A1		Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Bylund, Carma L.	University Of Florida United States	Dignity Therapy for Older Cancer Patients: Identifying Mechanisms and Moderators	5R01CA253330-03		Brennan Streck, Ph.D., RN, M.P.H.
Cai, Long	California Institute Of Technology United States	Understanding the role of tumor microenvironment in low grade glioma progression to malignancy	1U01CA294551-01		Sidney Fu, M.D.
Cantuaria, Guilherme	Northside Hospital Atlanta United States	Georgia NCI Community Oncology Research Program (GA NCORP)	5UG1CA189997-11		Vanessa A. White, M.P.H.
Cao, Yin	Washington University United States	PROSPECT-Global Consortium and Risk Factor Discovery	1OT2CA297576-01		Asad Umar, D.V.M., Ph.D.
Cao, Yin	Washington University United States	Obesity, sedentary behaviors, and diet quality for prevention and early detection of early-onset colorectal neoplasia	5R37CA246175-05		Asad Umar, D.V.M., Ph.D.
Cao, Shugeng	University Of Hawaii At Hilo United States	Discovery of novel natural TEAD inhibitors for the chemoprevention of liver tumors	5UG3CA290375-02		Altaf Mohammed, Ph.D.
Carlson, Jay W	Ozark Health Ventures, Llc United States	Ozark Health Ventures LLC dba Cancer Research for the Ozarks (CRO)	5UG1CA189822-11		Vanessa A. White, M.P.H.
Carson, Tiffany Lashaun	H. Lee Moffitt Cancer Ctr & Res Inst United States	Determining the structural- and functional-level effects of diet-specific interventions on the gut microbiota of a diverse sample of Southern United States adults	5R01CA253219-05		Young Kim, Ph.D.
Carter, Bob S	Massachusetts General Hospital United States	Standardized Molecular Analyses of Glioma EVs	5R01CA237500-05		Matthew Young, Ph.D.
Castilla, Lucio H.	Univ Of Massachusetts Med Sch Worcester United States	Study of tyrosine kinase inhibitors as preventive therapy in RUNX1-FPD	1U01CA296350-01		Marjorie Perloff, M.D.
Castro, Cesar M	Massachusetts General Hospital United States	Composing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approach	5U01CA279858-02		Christos Patriotis, Ph.D., M.Sc.
Caulin, Carlos	University Of Arizona United States	Genetic Alterations That Confer High Risk to Oral Premalignant Lesions	5R01CA274857-03	PA-20-185 (Parent R01 Clinical Trial Not Allowed)
Caywood, Emi H	Nemours Children'S Hospital, Delaware United States	Nemours NCI Community Oncology Research Program (NCORP)	5UG1CA189958-11		Vanessa A. White, M.P.H.
Chak, Amitabh	Case Western Reserve University United States	Pathways of Injury and Repair in Barrett's Carcinogenesis	5P01CA269019-02
Chan, Daniel Wanyui	Johns Hopkins University United States	Development of a panel of multiplex biomarkers for the early detection of pancreatic ductal adenocarcinoma and high-risk lesions	5U01CA274514-02	PAR-21-334 (U01 Clinical Trial Optional)	Matthew Young, Ph.D.
Chan, Andrew T	Massachusetts General Hospital United States	MGH- PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors	1OT2CA297680-01		Asad Umar, D.V.M., Ph.D.
Chan, Daniel Wanyui	Johns Hopkins University United States	BCC for Prostate Cancer: Discovery and Translation of Biomarkers for Clinical Unmet Needs	5U2CCA271895-02		Indu Kohaar, Ph.D., M.Phil., M.Sc.
Chan, Alexandre	University Of California-Irvine United States	Neurotrophic strategy to mitigate chemotherapy-related brain injury	5R01CA276212-02	PAR-21-329 (R01 Clinical Trial Optional)	John Clifford, Ph.D.
Chan, Andrew T	Massachusetts General Hospital United States	Precision Prevention Research Program	5R35CA253185-05		Asad Umar, D.V.M., Ph.D.
Chang, Su-Hsin	Washington University United States	Addressing racial disparities in monoclonal gammopathy of undetermined significance and progression to multiple myeloma from a prevention perspective	5R01CA253475-03		Asad Umar, D.V.M., Ph.D.
Chapkin, Robert Stephen	Texas A&M Agrilife Research United States	Targeting plasma membrane spatial dynamics to suppress aberrant Wnt signaling	5R01CA244359-05		Amit Kumar, Ph.D.
Chen, Ru	Baylor College Of Medicine United States	BLOOD-BASED PROTEOMIC ASSAY FOR PANCREATIC CANCER DETECTION	1UH2CA292130-01		Claire Zhu, Ph.D.
Cheville, Andrea Lynne	Mayo Clinic Rochester United States	Achieving Equity through SocioCulturally-informed, Digitally-Enabled Cancer Pain managemeNT” (ASCENT) Clinical Trial	5R33CA278594-03		Brennan Streck, Ph.D., RN, M.P.H.
Chiang, Cheng-Ming	Ut Southwestern Medical Center United States	Small Compound Inhibitors Targeting HPV Genome Replication	1R01CA288743-01A1
Chibwesha, Carla J	Univ Of North Carolina Chapel Hill United States	Acceptability and feasibility of combination treatment for cervical precancer among South Africa women living with HIV	5R01CA250850-05		Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Chinnaiyan, Arul M	University Of Michigan At Ann Arbor United States	Michigan-VUMC Biomarker Characterization Center	5U2CCA271854-03		Indu Kohaar, Ph.D., M.Phil., M.Sc.
Chirenje, Zvavahera Mike	University Of California, San Francisco United States	Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE)	5UG1CA284918-02		Maria Silvina Frech, Ph.D., M.S.
Chong, Catherine Daniela	Mayo Clinic Arizona United States	Biomarker Signature to Predict the Persistence of Post-Traumatic Headache	5R33NS113315-03		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Chung, Raymond T	Massachusetts General Hospital United States	Trial of Statins for Chemoprevention in Hepatocellular Carcinoma	5R01CA255621-04		Asad Umar, D.V.M., Ph.D.
Chung, Michael Hoonbae	Emory University United States	HIV/cervical cancer cOntrol and Prevention clinical sitE in Kenya (HOPE-Kenya)	5UG1CA275400-03		Maria Silvina Frech, Ph.D., M.S.
Chung, Ki Young	Prisma Health - Upstate United States	NCORP of the Carolinas (Greenville Health System NCORP)	5UG1CA189972-11		Vanessa A. White, M.P.H.
Clapper, Margie L.	Research Inst Of Fox Chase Can Ctr United States	Folic Acid Supplementation and Colitis-associated Colon Carcinogenesis	5R01CA262551-04	PA-20-185 (Parent R01 Clinical Trial Not Allowed)	Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Clapper, Margie L.	Research Inst Of Fox Chase Can Ctr United States	Novel small molecule agents to correct pathogenic VHL missense mutations	3U54CA272686-03S1	RFA-CA-21-038 (U54 Clinical Trial Not Allowed)
Clare, Susan E.	Northwestern University At Chicago United States	Lipid-initiated epigenetic reprogramming of the breast to a neural phenotype	1R21CA288676-01A1
Cocucci, Emanuele	Ohio State University United States	A SYNTHETIC BIOMARKER TO UNIVERSALLY ASSESS THE RELATIVE CONTRIBUTION OF HEATHY AND CANCEROUS TISSUE TO CIRCULATING EV POOL	5R01CA270251-03	PAR-20-053 (R01 Clinical Trial Not Allowed)	Matthew Young, Ph.D.
Cohen, Lorenzo	University Of Tx Md Anderson Can Ctr United States	Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery	5R01CA272565-02		Brennan Streck, Ph.D., RN, M.P.H.
Cohn, Barbara A	Public Health Institute United States	Discriminatory Mechanisms in Early-Onset and Lethal Prostate Cancer	5R01CA264519-04		Howard L. Parnes, M.D.
Cook, Linda S	University Of Colorado Denver United States	Improving Strategies for Cancer Reduction through Early-detection and ENgagement (I-SCREEN)	5UG1CA286941-02		Elyse LeeVan, M.D., M.P.H.
Counter, Christopher M	Duke University United States	Adapting K-MDS to detect KRAS-mutant ctDNA	5R21CA257816-03
Cremer, Miriam	Cleveland Clinic Lerner Com-Cwru United States	Single Visit Clinical Validation of ScreenFire, a Low-Cost HPV Test: Efficacy and Cost Effectiveness (SCALE)	5R01CA266059-04		Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Crowder, Sylvia	H. Lee Moffitt Cancer Ctr & Res Inst United States	The MIND-BC Study: MIND diet for Breast cancer Cognition	1R01CA299480-01		Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Curiel-Lewandrowski, Clara	University Of Arizona United States	Targeted Prevention for Non-Melanoma Skin Cancer	5P01CA229112-05
Curtis, Amarinthia E	Spartanburg Regional Medical Center United States	Upstate Carolina Consortium - Community Oncology Research Program	5UG1CA239762-06		Vanessa A. White, M.P.H.
Curtius, Kathleen M.	University Of California, San Diego United States	Multiscale modeling of spatiotemporal evolution in Barrett's esophagus	5R01CA270235-02
Damaj, M. Imad	Virginia Commonwealth University United States	Inhibition of NLRP3 inflammasome for the treatment of Chemotherapy-induced peripheral neuropathy	1R21CA296516-01		Rachel Altshuler, Ph.D.
Damaj, M. Imad	Virginia Commonwealth University United States	Targeting Sphingosine-1-phosphate (S1P1) receptors for the treatment of Aromatase Inhibitors-induced Musculoskeletal Symptoms	5R01CA272147-03	PAR-21-329 (R01 Clinical Trial Optional)	Rachel Altshuler, Ph.D.
Daniel-Macdougall, Carrie	University Of Tx Md Anderson Can Ctr United States	Prebiotic diet intervention to enhance the microbiome and immunotherapy response in melanoma	1R01CA291965-01		Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Dantzer, Robert	University Of Tx Md Anderson Can Ctr United States	The Metabolic Basis of Cancer-Related Fatigue	5R01CA193522-09		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Dasgupta, Piyali	Marshall University United States	Capsaicin and small cell lung cancer therapy	2R15CA161491-03		Gabriela Riscuta, M.D., CNS
Dashwood, Roderick H	Texas A&M University Health Science Ctr United States	Immunoepigenetic targeting of MHC regulators in FAP	5R01CA257559-03
Davis, Jennifer Sarah	University Of Kansas Medical Center United States	Colorectal cancer risk factors, risk prediction and blood-based biomarker by tumor consensus molecular subtype	7U01CA222163-04		Claire Zhu, Ph.D.
Debes, Jose Daniel	University Of Minnesota United States	Biomarkers for Early Detection of Hepatitis B-Related Hepatocellular Carcinoma in Hispanics	1R37CA297814-01		Sidney Fu, M.D.
Demb, Joshua Brian	University Of California, San Diego United States	Optimal early colorectal cancer screening initiation	4R00CA267181-03		Claire Zhu, Ph.D.
Demehri, Shadmehr	Massachusetts General Hospital United States	Immunosurveillance of breast glands with oncogenic germline mutations	5UG3CA290300-02		Altaf Mohammed, Ph.D.
Deng, Youping	University Of Hawaii At Manoa United States	Circulating lipid and miRNA markers for early detection of breast cancer among women with abnormal mammograms	5R01CA230514-05		Christos Patriotis, Ph.D., M.Sc.
Deng, Gary E	Sloan-Kettering Inst Can Research United States	Acupuncture to Improve Outcomes in Patients with Sepsis: a Randomized Controlled Trial	5R21CA286330-02		Goli Samimi, Ph.D., M.P.H.
Deng, Jie	University Of Pennsylvania United States	Placebo-Controlled Phase II Randomized Clinical Trial of Photobiomodulation Therapy in Head and Neck Cancer Survivors with Chronic Lymphedema	1R01CA289307-01A1		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Deng, Youping	University Of Hawaii At Manoa United States	Profiling genome-wide circulating ncRNAs for the early detection of lung cancer	5R01CA223490-05
Dhakal, Soma	Virginia Commonwealth University United States	Single-Molecule High-Confidence Detection of miRNA Cancer Biomarkers	5R61CA278445-03		Christos Patriotis, Ph.D., M.Sc.
Diaz, Juan Sebastian Gomez	University Of California At Davis United States	A miniaturized neural network enabled nanoplasmonic spectroscopy platform for label-free cancer detection in biofluids	5R01CA273253-03
Digirolamo, Gregory James	Univ Of Massachusetts Med Sch Worcester United States	Increasing Nodule Detection in Lung Cancer by Non-Conscious Detection of "Missed" Nodules and Machine Learning	5R01CA269903-04		Richard Mazurchuk, Ph.D.
Djuric, Zora	University Of Michigan At Ann Arbor United States	MyGI Diet for Colorectal Cancer Prevention	5R01CA255743-03		Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Doescher, Mark P	University Of Oklahoma Hlth Sciences Ctr United States	Oklahoma Tribal, Rural, Urban Cancer Screening Trial ACCESS Hub	3UG1CA287044-02S1		Elyse LeeVan, M.D., M.P.H.
Doolittle, Gary C.	University Of Kansas Medical Center United States	The University of Kansas Cancer Center's- MCA Rural NCORP	5UG1CA239767-06		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Drake, Richard R.	Medical University Of South Carolina United States	Targeted Isolation and Identification of Sialylated Glycoproteins in Cancer Tissues, Cells and Biofluids	5R33CA267226-03		Richard Mazurchuk, Ph.D.
Drescher, Charles	Swedish Medical Center, First Hill United States	The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site	5UG1CA189953-11		Vanessa A. White, M.P.H.
Dryden-Peterson, Scott Lee	Brigham And Women'S Hospital United States	A multilevel intervention (Potlako+) to improve timely cancer detection and treatment initiation	5R01CA236546-05		Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Dryden-Peterson, Scott	Brigham And Women'S Hospital United States	Botswana CASCADE Clinical Trials Site	5UG1CA275416-03		Maria Silvina Frech, Ph.D., M.S.
Duan, Bin	University Of Nebraska Medical Center United States	Flupirtine Analogue Synthesis and Screening for the Treatment of Chemotherapy-Induced Neuropathic Pain	1R21CA298918-01		Rachel Altshuler, Ph.D.
Eastham, James A	Sloan-Kettering Inst Can Research United States	Influence of intra-individual variability in serial screening samples on clinical decision-making for risk stratification and biopsy by a single PSA and additional markers	5U01CA266535-03	PAR-18-913 (U01 Clinical Trial Not Allowed)	Claire Zhu, Ph.D.
Eibl, Guido Erwin Michael	University Of California Los Angeles United States	Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma	5P01CA236585-05
Eickhoff, Jens	University Of Wisconsin-Madison United States	CP-CTNet Coordinating Center Year 6 - Aug 1, 2024 through July 31, 2025	3U24CA242637-05S1	RFA-CA-18-030 (U24 Clinical Trials Required)	Donald Johnsey
Eisenmann, Eric Daniel	Ohio State University United States	Damage-associated molecular patterns in chemotherapy toxicity	1R37CA299879-01		Rachel Altshuler, Ph.D.
El-Bayoumy, Karam E	Pennsylvania State Univ Hershey Med Ctr United States	Chemoprevention by Black Raspberry of Oral Cancer Induced by Tobacco Carcinogens: Translational Studies	5R01CA173465-10		Gabriela Riscuta, M.D., CNS
El-Serag, Hashem B	Baylor College Of Medicine United States	Multilevel factors associated with heterogeneity in risk of liver cancer within Hispanics with cirrhosis	3P01CA263025-03S1		Asad Umar, D.V.M., Ph.D.
Elenitoba-Johnson, Kojo S. J.	Sloan-Kettering Inst Can Research United States	Genomic biomarkers of splenic lymphoma	5R01CA255655-06
Elias, Kevin	Brigham And Women'S Hospital United States	Ovarian cancer risk stratification using circulating miRNAs to assess BRCAness	1R03CA283252-01		Christos Patriotis, Ph.D., M.Sc.
Ellerton, John A	Southern Nevada Cancer Research Fdn United States	NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Required)	5UG1CA189829-11		Vanessa A. White, M.P.H.
Ellsworth, Grant B.	Weill Medical Coll Of Cornell Univ United States	Partnership for Prevention of HPV-Associated Cancers in People Living with HIV: Brazil, Mexico, and Puerto Rico	5U54CA242639-06		Maria Silvina Frech, Ph.D., M.S.
Elmore, Joann G	University Of California Los Angeles United States	Optimizing the Human-Computer Interaction in Pathology: Understanding the Impact of Computer-Aided Diagnosis Tools on Pathologists' Interpretive Performance	1R01CA288824-01A1		Claire Zhu, Ph.D.
Esserman, Laura J	University Of California, San Francisco United States	Extending the Diversity, Reach, and Generalizability of the WISDOM Study	5R01CA237533-05		Claire Zhu, Ph.D.
Esserman, Laura J	University Of California, San Francisco United States	RISE UP for Breast Cancer	1R13CA294950-01		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Esserman, Laura J	University Of California, San Francisco United States	WISDOM: A platform to optimize subtype-specific screening and prevention	1P01CA281826-01A1		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Fabian, Carol J.	University Of Kansas Medical Center United States	Biomarker-Based Phase IIB Trial of (Bazedoxifene-Conjugated Estrogen) to Reduce Risk for Breast Cancer	5R01CA249437-04		Edward Sauter, M.D., Ph.D.
Fahrmann, Johannes F	University Of Tx Md Anderson Can Ctr United States	Blood-Based Biomarkers for Personalized Risk Assessment of Breast and Ovarian Cancer	5U01CA282216-02		Claire Zhu, Ph.D.
Faller, Bryan	Decatur Memorial Hospital United States	Heartland Cancer Research NCORP	5UG1CA189830-11		Vanessa A. White, M.P.H.
Fan, Rong	Yale University United States	Immuno-Serological Assays for Monitoring COVID19 in Patients with Hematologic Malignancies	3U01CA260507-02S3		Indu Kohaar, Ph.D., M.Phil., M.Sc.
Farrar, Christian T	Massachusetts General Hospital United States	Novel metabolomic contrast probes for human lung cancer characterization	5R01CA273010-03	PA-20-185 (Parent R01 Clinical Trial Not Allowed)	Guillermo Marquez, Ph.D.
Feng, Ziding	Fred Hutchinson Cancer Center United States	Consortium on Translational Research in Early Detection of Liver Cancer:Data Management and Coordinating Center (DMCC)	5U24CA230144-08		Guillermo Marquez, Ph.D.
Fiol, Guilherme Del	University Of Utah United States	GARDE: Scalable Clinical Decision Support for Individualized Cancer Risk Management	5U24CA274582-02		Christos Patriotis, Ph.D., M.Sc.
Fitzgibbon, Marian L.	University Of Illinois At Chicago United States	Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer Risk	5R01CA250390-05		Young Kim, Ph.D.
Flory, James H	Sloan-Kettering Inst Can Research United States	Managing metabolic disruption in pancreatic cancer to prevent weight loss and improve quality of life	5R21CA277464-02		Gabriela Riscuta, M.D., CNS
Flowers, Lisa C.	Emory University United States	Georgia Consortium to Eliminate Cervical Cancer in Women Living with HIV (GaCECC-WLWH)	5UG1CA284884-02		Maria Silvina Frech, Ph.D., M.S.
Flowers, Lisa C.	Emory University United States	Screening strategies and social determinants of health among people with high risk of anal cancer	5R01CA285198-02		Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Flynn, Kathryn E	Medical College Of Wisconsin United States	Symptom Monitoring using Patient-Reported Outcomes to Optimize Medication Use (SyMPTOM)	1R01CA285925-01A1
Forsberg, Flemming	Thomas Jefferson University United States	Prostate Cancer Diagnosis by Multiparametric Ultrasound	5R01CA252311-05		Richard Mazurchuk, Ph.D.
Freedland, Stephen Jay	Cedars-Sinai Medical Center United States	A Comparative Study of Risk Factors for Men with and without Prostate Cancer at the VA Medical Center in Durham	3R01CA280081-02S1		Young Kim, Ph.D.
Friday, Bret E.B.	Essentia Institute Of Rural Health United States	Essentia Health Community Cancer Research Program - NCORP	5UG1CA189812-11		Vanessa A. White, M.P.H.
Furuta, Saori	Case Western Reserve University United States	Normalizing arginine metabolism with sepiaptein for immunostimulatory-shift ofHER2+ breast cancer	5R01CA248304-05
Fuschiotti, Patrizia	University Of Pittsburgh At Pittsburgh United States	Develop IL13Ra1 for diagnosis of early-stage mycosis fungoides	5R21CA280445-02		Wendy Wang, Ph.D., M.Sc.
Garcia, Jose M.	Seattle Inst For Biomedical/Clinical Res United States	SArcopenia in Men with Prostate Cancer undergoing ADT (SAP-ADT)	5R01CA279220-02		Marjorie Perloff, M.D.
Geisler, Stefanie	Washington University United States	Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy	5R37CA267905-04	PAR-19-325 (R01 Clinical Trial Optional)	Asad Umar, D.V.M., Ph.D.
Germain, Doris A	Icahn School Of Medicine At Mount Sinai United States	Exploring ovarian-derived hormone STC1 as the mediator of the protective effect of breast feeding against breast cancer.	5R21CA270702-02	PAR-20-292 (R21 Clinical Trial Optional)	Marjorie Perloff, M.D.
Germain, Doris A	Icahn School Of Medicine At Mount Sinai United States	Investigating the efficacy of g-Tocotrienol for the prevention of post-partum breast cancer	1R01CA301372-01		Anda Vlad, M.D., Ph.D.
Ghamande, Sharad A.	Augusta University United States	Georgia CaRes	5UG1CA189851-11		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Ghobrial, Irene M.	Dana-Farber Cancer Inst United States	Molecular prediction of myeloma in African Americans	5U01CA271492-03	PAR-18-913 (U01 Clinical Trial Not Allowed)	Claire Zhu, Ph.D.
Ghobrial, Irene M.	Dana-Farber Cancer Inst United States	Myeloma multidimensional precancer atlas	1U01CA294507-01		Nick Hodges, Ph.D.
Ghosh, Jayashri	Temple Univ Of The Commonwealth United States	Development of blood-based methylation biomarkers for CRC risk prediction	5R01CA281948-02		Matthew Young, Ph.D.
Giles, Erin	University Of Michigan At Ann Arbor United States	Obesity, body fat distribution, and breast cancer risk: is visceral fat the culprit after menopause?	5R01CA269726-02	PA-20-185 (Parent R01 Clinical Trial Not Allowed)	Marjorie Perloff, M.D.
Godwin, Andrew K.	University Of Kansas Medical Center United States	Extracellular Vesicle Proteomic Fingerprinting of Ovarian Cancer for Early Detection with a Nanoengineered Microsystem	5R01CA260132-05		Matthew Young, Ph.D.
Goel, Ajay	Beckman Research Institute/City Of Hope United States	Exosomal Biomarkers for the Noninvasive Detection of Colorectal Cancer	5R01CA227602-05		Matthew Young, Ph.D.
Goel, Ajay	Beckman Research Institute/City Of Hope United States	Exosome-based microRNA biomarkers for Non-invasive and Early Detection of Pancreatic Cancer	5U01CA214254-07		Matthew Young, Ph.D.
Goel, Ajay	Beckman Research Institute/City Of Hope United States	Exosomal biomarkers for the early detection of hepatocellular carcinoma	5R01CA271443-02		Matthew Young, Ph.D.
Goggins, Michael G.	Johns Hopkins University United States	Using Markers to Improve Pancreatic Cancer Screening	5R01CA176828-10		Matthew Young, Ph.D.
Goggins, Michael G.	Johns Hopkins University United States	Using markers to improve pancreatic cancer screening and surveillance: a multi-center study	5U01CA210170-08		Matthew Young, Ph.D.
Goncalves, Marcus Dasilva	New York University School Of Medicine United States	Molecular Mechanisms of Fructose-induced Colorectal Cancer Cell Survival	5R01CA258697-05		Amit Kumar, Ph.D.
Gonzalez, Brian D	H. Lee Moffitt Cancer Ctr & Res Inst United States	Impact of Targeted Therapy on Cancer-Related Cognitive Impairment	1R01CA287666-01A1
Goode, Diana J	University Of New England United States	Novel expression of MHC class II on DRG neurons and its role in promoting antinociceptive CD4+ T cells in females during chemotherapy-induced peripheral neuropathy	5R01CA267554-03		Rachel Altshuler, Ph.D.
Grady, William Mallory	Fred Hutchinson Cancer Center United States	Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus	5U2CCA271902-03		Matthew Young, Ph.D.
Grady, William Mallory	Fred Hutchinson Cancer Center United States	Identifying Gut Microbial Inducers of Biological Aging in the Colon	3U54CA274374-03S4		Christos Patriotis, Ph.D., M.Sc.
Greene, Nicholas Perry	University Of Arkansas At Fayetteville United States	DEVELOPMENT OF TARGETED APPROACHES IN PREVENTION OF CANCER-CACHEXIA	5R01AR075794-05		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Grimm, Lars J	Duke University United States	Dynamic imaging and tissue biomarker models to delineate indolent from aggressive breast calcifications	5R01CA271237-03	PAR-19-264 (R01 Clinical Trial Optional)	Richard Mazurchuk, Ph.D.
Grogan, Eric L	Vanderbilt University Medical Center United States	Clinical Utility of a Combined Biomarker Approach to Diagnose Lung Cancer	5U01CA152662-13		Guillermo Marquez, Ph.D.
Grogan, Eric L	Vanderbilt University Medical Center United States	Clinical Utility of Biomarkers Driven Management of Indeterminate Pulmonary Nodules	5R01CA252964-05		Claire Zhu, Ph.D.
Groninger, J. Hunter	Medstar Health Research Institute United States	Cognitive behavioral theory-assisted virtual reality for chronic cancer pain (VR-CAN): device prototype development and feasibility testing	1R21CA299799-01		Brennan Streck, Ph.D., RN, M.P.H.
Gross, Howard M	Dayton Clinical Oncology Program United States	Dayton Clinical Oncology Program	5UG1CA189957-11		Vanessa A. White, M.P.H.
Grossman, Douglas	University Of Utah United States	Electrical impedance dermography as a biomarker for basal and squamous cell carcinoma	1R21CA289101-01A1		Nick Hodges, Ph.D.
Grueber, Wesley B	Columbia University Health Sciences United States	Neuron-macrophage interactions in models of chemotherapy-induced peripheral neuropathy	5R21CA274588-02		Rachel Altshuler, Ph.D.
Gudas, Lorraine J	Weill Medical Coll Of Cornell Univ United States	CD 1530, an RAR Gamma Agonist for Oral Cavity Squamous Cell Carcinoma Prevention	5R01CA270248-02
Halmos, Balazs	Montefiore Medical Center (Bronx, Ny) United States	MINORITY-BASED COMMUNITY ONCOLOGY PROGRAM	5UG1CA189859-11		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Hanash, Samir M	University Of Tx Md Anderson Can Ctr United States	Clinical Validation Center for Lung Cancer Early Detection	5U01CA271888-03		Guillermo Marquez, Ph.D.
Hanks, Brent Allen	Univ Of North Carolina Chapel Hill United States	Role of the tumor NLRP3 inflammasome in the generation of anti-PD-1 antibody immunotherapy-associated toxicities	7R01CA251136-05		Marjorie Perloff, M.D.
Hansen, Laura A	Creighton University United States	Targeting aberrant anti-apoptotic signaling for prevention of skin cancer	5R01CA253573-05		Howard L. Parnes, M.D.
Harichand, Seema	Iowa Oncology Research Association United States	Iowa-Wide Oncology Research Coalition (I-WORC)	5UG1CA189816-11		Vanessa A. White, M.P.H.
Harris, Holly Ruth	Fred Hutchinson Cancer Center United States	Risk factors for and consequences of endometriosis among Black women	1R21HD115018-01		Goli Samimi, Ph.D., M.P.H.
Hartman, Terryl J.	Emory University United States	Fiber-rich Foods to Treat Obesity and Prevent Colon Cancer	5R01CA245063-05		Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Hawkins, Shannon Michelle	Indiana University Indianapolis United States	Targeting cellular senescence to inhibit the development and progression of ovarian endometriomas	5R01HD109707-03	PA-20-185 (Parent R01 Clinical Trial Not Allowed)	Goli Samimi, Ph.D., M.P.H.
Hayes, Richard Bernard	New York University School Of Medicine United States	The Oral Microbiome and Upper Aerodigestive Squamous Cell Cancer	5R01CA159036-09		Claire Zhu, Ph.D.
Hecht, Stephen S	University Of Minnesota United States	High resolution mass spectrometric profile analysis of carcinogen-DNA adducts in oral cells of cigarette smokers and squamous cell carcinoma of the head and neck	5R01CA263084-04	PA-20-185 (Parent R01 Clinical Trial Not Allowed)	Wendy Wang, Ph.D., M.Sc.
Heine, John J	H. Lee Moffitt Cancer Ctr & Res Inst United States	Quantitative Imaging Clinical Validation Center at Moffitt Cancer Center	5U01CA200464-07		Richard Mazurchuk, Ph.D.
Herman, James G.	University Of Pittsburgh At Pittsburgh United States	Optimizing Ultrasensitive DNA methylation detection for lung cancer and other malignancies	5U2CCA271885-03		Wendy Wang, Ph.D., M.Sc.
Herrmann, Joerg	Mayo Clinic Rochester United States	TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) Trial	5R01CA233610-06		Eileen Dimond, R.N., M.S.
Hilakivi-Clarke, Leena A.	University Of Minnesota United States	Effect of maternal obesity on breast cancer among offspring: role of the gut microbiota	5R01CA276775-02		Amit Kumar, Ph.D.
Hill, Joshua Aiden	Fred Hutchinson Cancer Center United States	Immunoglobulin Replacement Therapy and Infectious Complications After CD19-Targeted CAR-T-Cell Therapy	5R01CA276040-02		Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Hirsch, Fred R	Icahn School Of Medicine At Mount Sinai United States	Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses	3U54CA260560-02S3		Guillermo Marquez, Ph.D.
Hitchins, Megan P	Cedars-Sinai Medical Center United States	Discovery and verification of methylated circulating tumor DNA markers for the detection of colorectal cancer in subjects under 50 years of age	5R01CA252042-04	PA-20-185 (Parent R01 Clinical Trial Not Allowed)	Matthew Young, Ph.D.
Hoffman, Amy Jude	University Of Nebraska Medical Center United States	Managing Fatigue Using Virtual Reality for Post-Operative Lung Cancer Patients	5R01CA205025-06		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Hollingsworth, Michael A.	University Of Nebraska Medical Center United States	Pancreatic Cancer Detection Consortium	5U01CA210240-08		Matthew Young, Ph.D.
Hoshida, Yujin	Ut Southwestern Medical Center United States	Epigallocatechin gallate for prevention of lethal cirrhosis complications	5R01CA282178-02		Asad Umar, D.V.M., Ph.D.
Hoshida, Yujin	Ut Southwestern Medical Center United States	Reverse-engineering precision liver cancer chemoprevention	3R01CA233794-05S1		Marjorie Perloff, M.D.
Hoshida, Yujin	Ut Southwestern Medical Center United States	Therapeutic modulation of a proteomic HCC risk signature with statins in patients with liver cirrhosis	5U01CA288375-02		Matthew Young, Ph.D.
Houghton, A Mcgarry	Fred Hutchinson Cancer Center United States	Tumor-specific autoantibodies for SCLC early detection	5R01CA243328-06		Guillermo Marquez, Ph.D.
Hsu, Li	Fred Hutchinson Cancer Center United States	Statistical Methods for Precision Prevention	1R01CA297681-01		Claire Zhu, Ph.D.
Hu, Jim	Weill Medical Coll Of Cornell Univ United States	Pelvic fascia spARing radical prostatectomy TrIAL (PARTIAL)	5R01CA259173-03		Marjorie Perloff, M.D.
Hu, Shuiying	Ohio State University United States	Targeting neuronal transport to ameliorate vincristine neurotoxicity	5R01CA272254-02		Rachel Altshuler, Ph.D.
Huang, Ying	Fred Hutchinson Cancer Center United States	Accelerating biomarker development through novel statistical methods for analyzing phase III/IV studies	5R01CA277133-03		Matthew Young, Ph.D.
Huang, Yijian	Emory University United States	Analytic diagnosis methods for disease ruling	1R01CA283687-01A1		Guillermo Marquez, Ph.D.
Huang, Ying	Western University Of Health Sciences United States	Preventing UV-induced immunosuppression and skin carcinogenesis with R-carvedilol	5R01CA269653-03
Huberty, Jennifer Lynne	University Of Texas Hlth Science Center United States	Consumer-based meditation app, Calm, for treatment of sleep disturbance in hematological cancer patients	5R01CA262041-05		Marjorie Perloff, M.D.
Huh, Warner King	University Of Alabama At Birmingham United States	Misoprostol to Optimize Prevention of Cancer of the Cervix: A Randomized Trial (MISOPCx Project)	1R01CA279021-01A1		Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Hui, David	University Of Tx Md Anderson Can Ctr United States	Strategies for Personalizing Oxygen and support Therapies for dyspnea in Oncology	5R01CA288515-02		Brennan Streck, Ph.D., RN, M.P.H.
Hundley, William Gregory	Wake Forest University Health Sciences United States	Improving Exercise Capacity with a Tailored Physical Activity Intervention in Lymphoma Patients Undergoing Treatment	5R33CA226960-05		Eileen Dimond, R.N., M.S.
Hur, Chin	Columbia University Health Sciences United States	Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype	3R01CA257333-04S1		Matthew Young, Ph.D.
Huttenhower, Curtis	Broad Institute, Inc. United States	PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors	1OT2CA297578-01		Asad Umar, D.V.M., Ph.D.
Ibsen, Stuart Duncan	Oregon Health & Science University United States	Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers	5R37CA258787-04		Matthew Young, Ph.D.
Im, Eun-Ok	University Of Texas At Austin United States	Cancer Pain Management: A Technology-Based Intervention for Asian American Breast Cancer Survivors	5R33CA280979-03		Brennan Streck, Ph.D., RN, M.P.H.
Infante, Rodney E	Ut Southwestern Medical Center United States	Identifying the Cellular and Molecular Targets of JAK/STAT-Driven Adipose Wasting to Reverse Cancer Cachexia	3R01CA266900-03S1	PA-20-185 (Parent R01 Clinical Trial Not Allowed)	Marjorie Perloff, M.D.
Irvin, William J	Southeast Clinical Oncol Res Consortium United States	NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Required)	5UG1CA189858-11		Vanessa A. White, M.P.H.
Iwelunmor, Juliet	Washington University United States	Innovative Rapid Enabling, Affordable, point-of-Care HPV Self-Testing Strategy (I-REACH)	5U01CA279863-03		Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Iyer, Prasad G.	Mayo Clinic Rochester United States	Minimally Invasive Molecular Approaches for the Detection of Barrett’s Esophagus and Esophageal Adenocarcinoma	5R01CA241164-06		Matthew Young, Ph.D.
Jacob, Jennifer B	Henry Ford Health + Michigan State University Health Sciences United States	Defining Cancer Intervention Targets by Functional Genomics Analysis of Outbred F1 Mice	5R01CA278818-03
James, Aimee S	Washington University United States	Building equity in cancer screening through research: The Siteman Catchment CSRN Hub	5UG1CA286946-02		Elyse LeeVan, M.D., M.P.H.
Jang, Mi-Hyeon	Rutgers Biomedical And Health Sciences United States	Identification of novel biomarkers and therapeutic strategies in chemobrain.	5R01CA293210-02		John Clifford, Ph.D.
Jaslowski, Anthony J	St. Vincent Hospital United States	Cancer Research of Wisconsin and Northern Michigan (CROWN) Consortium	5UG1CA239769-06		Vanessa A. White, M.P.H.
Ji, Hanlee P	Stanford University United States	Single-molecule nanopore-based identification of methylome signatures in cfDNA for early colorectal cancer detection	1U01CA282212-01A1		Claire Zhu, Ph.D.
Ji, Hanlee P	Stanford University United States	Precision Interception of Gastric Cancer Precursors Through Molecular and Cellular Risk Stratification	5P01CA265772-02		Asad Umar, D.V.M., Ph.D.
Jiang, Qing	Purdue University United States	Anti-cancer effects of tocotrienols and a carboxychromanol in an innovative colon cancer model	5R03CA283236-02		Amit Kumar, Ph.D.
Jim, Heather S.L.	H. Lee Moffitt Cancer Ctr & Res Inst United States	Adaptation and Preliminary Evaluation of Energize-MBC: Cognitive Behavioral Therapy for Fatigue among Women with Metastatic Breast Cancer	1R34CA289918-01		Brennan Streck, Ph.D., RN, M.P.H.
Jobin, Christian	University Of Florida United States	Interaction between dietary taurine and microbiota sulfur metabolism in the development of colorectal cancer	1R01CA296643-01		Young Kim, Ph.D.
John, Esther M.	Stanford University United States	Stress, inflammation, and health-related quality of life of long-term breast cancer survivors	1R21CA290430-01		Brennan Streck, Ph.D., RN, M.P.H.
Johnson, Constance Margaret	University Of Texas Hlth Sci Ctr Houston United States	Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy	3R01CA245054-05S1		Rachel Altshuler, Ph.D.
Johnson, Jeremy James	University Of Illinois At Chicago United States	Defining the role of isoprenylated xanthones from the mangosteen for enhancing degradation of full length and variant forms of androgen receptor in prostate cancer	5R37CA227101-07		Amit Kumar, Ph.D.
Judge, Andrew Robert	University Of Florida United States	The Complement System and Cancer Cachexia	5R01AR081648-03		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Justilien, Verline	Mayo Clinic Jacksonville United States	ECT2 Isoform Switch in Pancreatic Cancer.	1R21CA296671-01		Matthew Young, Ph.D.
Kachnic, Lisa A.	Columbia University Health Sciences United States	Columbia University Minority/Underserved Site NCI Community Oncology Research Program	5UG1CA189960-11		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Kahalley, Lisa Schum	Baylor College Of Medicine United States	Comparison of Symptom Burden/Toxicity, Neurocognitive Change, and Functional Outcomes in Pediatric Brain Tumor Patients Treated with Proton vs. Photon Radiotherapy.	5R01CA249988-04		Rachel Altshuler, Ph.D.
Kalluri, Raghu	University Of Tx Md Anderson Can Ctr United States	Rigorous and reproducible mutational analysis of the urinary exosomal DNA	5R01CA231465-05		Matthew Young, Ph.D.
Kanarek, Naama	Boston Children'S Hospital United States	Mechanistic Study of Methotrexate-Induced Oxidative Distress in Neurons and the CSF	5R01CA282477-02		John Clifford, Ph.D.
Kanetsky, Peter A	H. Lee Moffitt Cancer Ctr & Res Inst United States	A hybrid effectiveness-implementation trial to integrate precision skin cancer risk feedback in federally qualified health centers	1R01CA291735-01		Claire Zhu, Ph.D.
Kang, Dongkyun	University Of Arizona United States	Non-invasive, quantitative microscopic biomarkers for chemotherapy-induced peripheral neuropathy	1R01CA301271-01		Rachel Altshuler, Ph.D.
Kanwal, Fasiha	Baylor College Of Medicine United States	Risk Stratification for and Early Detection of Liver Cancer	5U01CA230997-07		Sidney Fu, M.D.
Kassie, Fekadu	University Of Minnesota United States	Targeting tumor cell mitochondria for the prevention and treatment of lung cancer	1R01CA285608-01A1
Kassie, Fekadu	University Of Minnesota United States	Lung cancer prevention and treatment by targeting ALDH1 and CD44 expressing putative lung cancer stem cells	5R01CA231210-05		Marjorie Perloff, M.D.
Kelleher, Sarah	Duke University United States	Initial Testing of a Mobile App Pain Coping Intervention for Outpatient Oncology Settings	5R21CA273832-02		Brennan Streck, Ph.D., RN, M.P.H.
Kelleher, Sarah	Duke University United States	Randomized Controlled Trial of a Hybrid-Delivered Cognitive Behavioral Symptom Management and Activity Coaching Intervention for Stem Cell Transplant Patients	1R01CA291888-01		Brennan Streck, Ph.D., RN, M.P.H.
Khan, Seema Ahsan	Northwestern University At Chicago United States	Determinants of transdermal drug delivery to the normal and the radiated breast	5R01CA235647-05		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Khan, Seema Ahsan	Northwestern University At Chicago United States	Northwestern Cancer Prevention Consortium	5UG1CA242643-06		Donald Johnsey
Khasabov, Sergey G	University Of Minnesota United States	Treatment of cancer pain by lipid mediator Resolvin D1: role of Prostaglandin and Endocannabinoid signaling	5R01CA263777-04		Rachel Altshuler, Ph.D.
Kibel, Adam S	Brigham And Women'S Hospital United States	Polygenic risk stratification combined with mpMRI to identify clinically relevant prostate cancer	5U01CA268810-02		Richard Mazurchuk, Ph.D.
Kim, Michelle Kang	Cleveland Clinic Lerner Com-Cwru United States	Assessing feasibility of gastric cancer screening in the US	1R37CA300540-01		Claire Zhu, Ph.D.
Kim, Hyung L	Cedars-Sinai Medical Center United States	Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer	5R01CA280060-02		Howard L. Parnes, M.D.
King, Suzanne N	University Of Louisville United States	Mechanisms underlying radiation-induced dysphagia	5R21CA263107-02	PAR-20-292 (R21 Clinical Trial Optional)	Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Kirkwood, Kimberly Saunders	University Of California, San Francisco United States	Using microvolumetric cyst fluid proteolysis for early detection of pancreatic cancer	5U01CA282269-02		Matthew Young, Ph.D.
Kisiel, John	Mayo Clinic Rochester United States	Multi-cancer Early Detection	2R01CA214679-08		Matthew Young, Ph.D.
Kisiel, John	Mayo Clinic Rochester United States	Multi-site Gastrointestinal Cancer Detection by Stool DNA Methylation	5R37CA214679-07		Matthew Young, Ph.D.
Kleckner, Amber Simmons	University Of Maryland Baltimore United States	Time-restricted eating to address cancer-related fatigue among survivors of hematological malignancies	1R01CA284082-01A1		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Klein, Alison P	Johns Hopkins University United States	Improving Management of patients at High Risk of Pancreatic Cancer	1R01CA299421-01		Matthew Young, Ph.D.
Knoerl, Robert James	University Of Michigan At Ann Arbor United States	Determining the Feasibility of Virtual Tailored, Music-Based Relaxation for Anxiety Among Adolescent and Young Adult Cancer Survivors.	1R34CA286712-01A1		Goli Samimi, Ph.D., M.P.H.
Kober, Kord Michael	University Of California, San Francisco United States	An Investigation of the Molecular Mechanisms for and Prediction of the Severity of Cancer Chemotherapy-Related Fatigue Using a Multi-staged Integrated Omics Approach	4R37CA233774-06		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Kolb, Noah Allan	University Of Vermont & St Agric College United States	Remote Monitoring of Management of Chemotherapy induced Peripheral Neuropathy	5R01CA247517-05		Brennan Streck, Ph.D., RN, M.P.H.
Kong, Mei	University Of California-Irvine United States	Using dietary glutamine supplementation for melanoma prevention and targeted therapy	5R01CA244360-04	PA-20-185 (Parent R01 Clinical Trial Not Allowed)	Gabriela Riscuta, M.D., CNS
Kooperberg, Charles L	Fred Hutchinson Cancer Center United States	Statistics and Data Management Center (SDMC) for the NCI Cancer Screening Research Network (CSRN)	5UG1CA287013-02		Elyse LeeVan, M.D., M.P.H.
Krist, Alexander H	Virginia Commonwealth University United States	Virginia Cancer Screening Research Network Access Hub (Virginia CSRN Hub)	3UG1CA287017-02S1		Elyse LeeVan, M.D., M.P.H.
Kroetz, Deanna L	Ohio State University United States	Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity	5R01CA261068-06		Rachel Altshuler, Ph.D.
Kuhn, Peter	University Of Southern California United States	Multi-modal Liquid Biopsy Early Assessment of Breast Cancer, Pancreatic Cancer, and Multiple Myeloma	5U01CA285013-02
Kuhs, Krystle A.	University Of Kentucky United States	Circulating HPV DNA as a Prediagnostic Marker of Oropharyngeal Cancer	5R21CA267152-02		Wendy Wang, Ph.D., M.Sc.
Kumar, Nagi B.	H. Lee Moffitt Cancer Ctr & Res Inst United States	Phase II Clinical trial of GTC in Men on Active Surveillance	5R01CA235032-06		Howard L. Parnes, M.D.
Labaer, Joshua	Arizona State University-Tempe Campus United States	Multiplex In-Solution Protein Array (MISPA) for high throughput, quantitative, early profiling of pathogen-induced head and neck	5R33CA281802-02		Wendy Wang, Ph.D., M.Sc.
Labaer, Joshua	Arizona State University-Tempe Campus United States	High-throughput immunoproteomics for cancer biomarker discovery	5U2CCA271903-03		Christos Patriotis, Ph.D., M.Sc.
Lampe, Paul D	Fred Hutchinson Cancer Center United States	Autoantibodies to tumor-derived neoepitopes as biomarkers and immunoPET agents for the early detection of small cell lung cancer	5R01CA281801-02		Richard Mazurchuk, Ph.D.
Langel, Stephanie N.	Case Western Reserve University United States	Antibody bound bacteria during HPV infection and cervical dysplasia	1R21CA289927-01		Goli Samimi, Ph.D., M.P.H.
Langevin, Anne-Marie R.	University Of Texas Hlth Science Center United States	Texas Pediatric NCORP MU	5UG1CA189855-11		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Largaespada, David Andrew	University Of Minnesota United States	Recurrent Tumor-Specific Alternately Processed Transcripts as a Source of Neoantigens for NF1-associated Malignant Peripheral Nerve Sheath Tumor Immunoprevention	5UH3CA244687-05
Leal, Ana Sofia Mendes	Indiana University Indianapolis United States	Nrf2, immune cells and lung cancer	7R01CA226690-06		Marjorie Perloff, M.D.
Lee, Hakho	Massachusetts General Hospital United States	Expanding early cancer detection with high throughput OCEANA - Ovarian Cancer Exosome Analysis with Nanoplasmonic Array	5U01CA284982-02
Lee, Juhun	University Of Pittsburgh At Pittsburgh United States	Detecting Mammographically-Occult Cancer in Women with Dense Breasts Using Digital Breast Tomosynthesis	5R01CA269540-03		Sidney Fu, M.D.
Lee, Jeffrey Kuang Zou	Kaiser Foundation Research Institute United States	Vanguard Study Administrative Supplement	3UG1CA287011-02S1		Elyse LeeVan, M.D., M.P.H.
Lee, Richard T	Beckman Research Institute/City Of Hope United States	A Pilot Study to Evaluate the Benefits of Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy	1R21CA260447-01A1		Rachel Altshuler, Ph.D.
Lehto, Rebecca H	Henry Ford Health + Michigan State University Health Sciences United States	Support for bereaved friend and family caregivers of cancer patients	1R03CA282943-01A1		Brennan Streck, Ph.D., RN, M.P.H.
Lenburg, Marc Elliott	Boston University Medical Campus United States	The Boston University - UCLA Lung Cancer Biomarker Characterization Center	5U2CCA271898-03		Guillermo Marquez, Ph.D.
Lesch, Bluma J	Yale University United States	Defining signatures of epigenetic sensitization to lung cancer in a mouse model	1R21CA288677-01		Guillermo Marquez, Ph.D.
Lesser, Glenn J	Wake Forest University Health Sciences United States	Wake Forest NCORP Research Base	3UG1CA189824-11S1		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Li, Yong	Baylor College Of Medicine United States	DELINEATE THE TUMOR IMMUNE MICROENVIRONMENT FOR BETTER UNDERSTANDING IMMUNOTHERAPY RESPONSE	3U54CA272691-02S1		Anda Vlad, M.D., Ph.D.
Li, Chi	University Of Louisville United States	A lung cancer vaccine based on exosomes of induced pluripotent stem cells	1R21CA280453-01		John Clifford, Ph.D.
Li, Christopher I	Fred Hutchinson Cancer Center United States	Fred Hutchinson Breast Cancer Clinical Validation Center	5U01CA152637-14		Sidney Fu, M.D.
Li, Bing	University Of Iowa United States	E-FABP mediates n-3 fatty acid-induced tumor prevention through epigenetic control of immune cell differentiation and function	5R01CA180986-11		Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Li, Bo	Children'S Hosp Of Philadelphia United States	Tracking Peripheral T-Cell Repertoire Changes for Preoperative and Early Ovarian Cancer Diagnosis	5R01CA258524-05		Christos Patriotis, Ph.D., M.Sc.
Li, Feng	University Of California Los Angeles United States	Novel ultra-short cell free DNA biomarkers for early detection of non-small cell lung cancer.	5R21CA283665-02		Guillermo Marquez, Ph.D.
Li, Debiao	Cedars-Sinai Medical Center United States	Predicting Pancreatic Ductal Adenocarcinoma PDAC Through Artificial Intelligence Analysis of Pre Diagnostic CT Images in African Americans	3R01CA260955-04S1		Matthew Young, Ph.D.
Liang, Han	University Of Tx Md Anderson Can Ctr United States	The Cancer Proteome Atlas: an Integrated Bioinformatics Resource for Functional Cancer Proteomic Data	5U24CA264128-03		Christos Patriotis, Ph.D., M.Sc.
Ligibel, Jennifer A.	Dana-Farber Cancer Inst United States	Distance-based Exercise to preserve Function and prevENt Disability (DEFEND)	1U34CA293568-01		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Lin, Po-Ju	University Of Rochester United States	Assessing the role of the interoceptive brain system in the pathophysiology and treatment of chemotherapy-induced peripheral neuropathy	1R21CA256154-01A1	PAR-20-292 (R21 Clinical Trial Optional)	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Lin, Jia-Ren	Harvard Medical School United States	Advancing technologies for the collection and analysis of high dimensional immunoprofiles and tumor images	5R50CA274277-03		Richard Mazurchuk, Ph.D.
Lin, Daniel W.	Fred Hutchinson Cancer Center United States	Prostate cancer Active Surveillance Study (PASS) Cohort: Infrastructure Support for Cancer Research	5U01CA224255-06		Richard Mazurchuk, Ph.D.
Lindau, Stacy Tessler	University Of Chicago United States	Bionic Breast Project: A Neuroprosthesis to Restore Touch Sensation and Reduce Chronic Pain After Mastectomy	5R01CA281301-02		Marjorie Perloff, M.D.
Linnes, Jacqueline	Purdue University United States	Point-of-care screening test for early cervical cancer detection	5R01CA246315-05		Christos Patriotis, Ph.D., M.Sc.
Lipkin, Steven M	Weill Medical Coll Of Cornell Univ United States	CAP-IT Center for LNP RNA Immunoprevention	5U54CA272688-03		John Clifford, Ph.D.
Liu, Yang	University Of Illinois At Urbana-Champaign United States	Imaging nanoscale chromatin folding in early carcinogenesis	5R01CA254112-07		Matthew Young, Ph.D.
Liu, Changchun	University Of Connecticut Sch Of Med/Dnt United States	Low-Cost CRISPR-on-Paper for Cervical Cancer Screening at the Point of Care	5U01CA269147-04		Christos Patriotis, Ph.D., M.Sc.
Livneh, Zvi	Weizmann Institute Of Science United States	Analysis of the predictability of lung cancer using DNA Repair functional assays and cryopreserved blood samples of the PLCO prospective cohort	5U01CA279001-03		Claire Zhu, Ph.D.
Lokshin, Anna E	University Of Pittsburgh At Pittsburgh United States	Development of Novel Ovarian Cancer Biomarkers for Early Detection Algorithms	5R01CA247220-05		Christos Patriotis, Ph.D., M.Sc.
Lokshin, Anna E	University Of Pittsburgh At Pittsburgh United States	Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer	5R01CA254036-05		Matthew Young, Ph.D.
Lowry, Kathryn Paige	University Of Washington United States	Evaluation of Commercial Mammography-Based Artificial Intelligence Algorithms for Breast Cancer Risk Prediction in U.S. Screening Populations	1R37CA292399-01		Claire Zhu, Ph.D.
Lu, Junxuan	Pennsylvania State Univ Hershey Med Ctr United States	Early clinial trials for Angelica herbal supplements for prostate cancer interception	5R01CA260901-03	PAR-21-035 (R01 Clinical Trial Required)	Gabriela Riscuta, M.D., CNS
Lubman, David M.	University Of Michigan At Ann Arbor United States	Serum Glyco-Markers of Early Hepatocellular Carcinoma Using a Mass Spec Approach	5R01CA160254-13		Matthew Young, Ph.D.
Lyden, David Charles	Weill Medical Coll Of Cornell Univ United States	Application of 4D proteomics and super-resolution microscopy in extracellular vesicle and particle-borne biomarker discovery for early pancreatic cancer detection	5R01CA218513-07		Matthew Young, Ph.D.
Maclean, Paul S.	University Of Colorado Denver United States	Novel dietary interventions for reducing obesity-associated breast cancer	5R01CA258766-04		Young Kim, Ph.D.
Madeleine, Margaret M	Fred Hutchinson Cancer Center United States	Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center	5U54CA242977-07		Maria Silvina Frech, Ph.D., M.S.
Mahan, Kristin Eckel	University Of Texas Hlth Sci Ctr Houston United States	Circadian regulation of astrocytic adenosine kinase in the irradiated and cancer brain	1R21CA292148-01		John Clifford, Ph.D.
Maitra, Anirban	University Of Tx Md Anderson Can Ctr United States	Clinical Validation Center for Early Detection of Pancreatic Cancer	5U01CA200468-08		Matthew Young, Ph.D.
Majumder, Shounak	Mayo Clinic Rochester United States	Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer	5U01CA210138-08		Matthew Young, Ph.D.
Maldonado, Fabien	Vanderbilt University Medical Center United States	Novel Integrative Approach for the Early Detection of Lung Cancer using Repeated Measures	5R01CA253923-05		Richard Mazurchuk, Ph.D.
Mallery, Susan R	Ohio State University United States	Formulation, Evaluation, and Phase 0 Trial of Nanoparticle Releasing Oral Thin Film for OSCC Chemoprevention	5R01CA258757-03		Malgorzata Wojtowicz, M.D.
Mallery, Susan R	Ohio State University United States	Assessment of Chemopreventive Effects of a Mucoadhesive Fenretinide Patch on Premalignant Oral Epithelial Lesions	5R01CA227273-06		Malgorzata Wojtowicz, M.D.
Mallick, Parag Kumar	Stanford University United States	Pathomic Predictors of Prostate Cancer Progression	5R01CA249899-05		Richard Mazurchuk, Ph.D.
Mantis, Nicholas J.	Wadsworth Center United States	High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology	3U01CA260508-02S1		Indu Kohaar, Ph.D., M.Phil., M.Sc.
Mao, Jun J	Sloan-Kettering Inst Can Research United States	Enhanced Pain Coping in Cancer (EPIC)	1R01CA285746-01A1		Rachel Altshuler, Ph.D.
Mao, Jun J	Sloan-Kettering Inst Can Research United States	Dopamine Metabolism and Nonpharmacologic Insomnia Interventions Among Cancer Survivors	5R21CA274059-02		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Marchand, Loic Le	University Of Hawaii At Manoa United States	Effects of Intermittent Energy Restriction on Intra-Abdominal Fat and the Gut Microbiome: A Randomized Trial	5R01CA258179-04	RFA-CA-20-004 (R01 Clinical Trial Optional)	Gabriela Riscuta, M.D., CNS
Marchetti, Dario	University Of New Mexico Health Scis Ctr United States	Mechanisms of melanoma brain metastasis by CTCs isolated from patients' blood and CSF	5R01CA216991-07		Matthew Young, Ph.D.
Marker, Ryan J	University Of Colorado Denver United States	Effects of a telehealth exercise program for rural cancer survivors with cancer-related fatigue including integrated longitudinal assessments of objective physical function and fatty acid oxidation	1R01CA292482-01		Goli Samimi, Ph.D., M.P.H.
Markowitz, Sanford D.	Case Western Reserve University United States	A Clinical Trial of Cancer Prevention by Biomarker Based Detections of Barrett's Esophagus and Its Progression	1R01CA295877-01
Markowitz, Sanford D.	Case Western Reserve University United States	Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablation	5U01CA271867-03		Matthew Young, Ph.D.
Marshall, David T.	Medical University Of South Carolina United States	Medical University of South Carolina NCORP Minority/Underserved Community Site	5UG1CA189848-11		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Martinez-Conde, Susana	Suny Downstate Medical Center United States	Novel Perceptual and Oculomotor Heuristics for Enhancing Radiologic Performance	5R01CA258021-04		Richard Mazurchuk, Ph.D.
Masters, Gregory A	Christiana Care Health Services, Inc. United States	Delaware Christiana Care NCORP	5UG1CA189819-11		Vanessa A. White, M.P.H.
Matin, Khalid	Virginia Commonwealth University United States	VCU Massey Cancer Center Minority/Underserved NCI Community Oncology Research Program	5UG1CA189869-11		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Mcguire, Andrew	Fred Hutchinson Cancer Center United States	Rational Vaccine Design to prevent HIV-Associated Lymphoma	5R01CA285227-02
Mclouth, Laurie	University Of Kentucky United States	Pathways, a Hope-Based Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life during Advanced Lung Cancer Treatment	5R01CA283929-02		Brennan Streck, Ph.D., RN, M.P.H.
Md, Nicholas Dibella	Western States Cancer Research Ncorp United States	Western States Cancer Research NCORP	5UG1CA189805-11		Vanessa A. White, M.P.H.
Meghani, Salimah H.	University Of Pennsylvania United States	Cannabis use and outcomes in ambulatory patients with cancer: A 12-month cohort study	5R01CA270483-04	PA-18-917 (R01 - Clinical Trial Optional)	Gabriela Riscuta, M.D., CNS
Mehrara, Babak J	Sloan-Kettering Inst Can Research United States	Mechanisms of racial disparity in breast cancer-related lymphedema	5R01CA278599-03
Mehta, Anand S.	Medical University Of South Carolina United States	Glycan Biomarkers for Cholangiocarcinoma	1R01CA289381-01A1		Sidney Fu, M.D.
Melemedjian, Ohannes Kevork	University Of Maryland Baltimore United States	Identification of novel targets for the treatment of chemotherapy-induced painful peripheral neuropathy	4R01CA249939-02		Rachel Altshuler, Ph.D.
Mello-Thoms, Claudia R	University Of Iowa United States	Satisfaction of Search in Breast Cancer Detection	5R01CA259048-05		Richard Mazurchuk, Ph.D.
Metzger, Gregory John	University Of Minnesota United States	Computer Aided Diagnostic System for Prostate Cancer Detection Using Quantitative Multiparametric MRI	5R01CA241159-04		Richard Mazurchuk, Ph.D.
Milanovich, Samuel J	Sanford Research/Usd United States	Sanford Community Cancer Program of the North Central Plains (NCORP)	5UG1CA189825-11		Vanessa A. White, M.P.H.
Milbury, Kathrin	University Of Tx Md Anderson Can Ctr United States	Dyadic yoga Program for Patients with Lung Cancer Undergoing Radiotherapy and their Family Caregivers	4R37CA231522-07		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Morilak, David A	University Of Texas Hlth Science Center United States	Therapy-induced cognitive impairment in a rat model of prostate cancer	5R01CA285183-02		John Clifford, Ph.D.
Moscicki, Anna-Barbara	University Of California Los Angeles United States	Real-world effectiveness of HPV vaccine in women living with HIV and its impact on cervical cancer screening accuracies	5R01CA281293-03		Maria Silvina Frech, Ph.D., M.S.
Mosher, Catherine E	Indiana University Indianapolis United States	Acceptance and Commitment Therapy for Patient Fatigue Interference and Caregiver Burden in Advanced Gastrointestinal Cancer	5R01CA289486-02
Mu, Ping	Yale University United States	Unveiling the Role of UBE2J1 as the E2 Ubiquitin Conjugating Enzyme in Androgen Receptor Degradation	7R01CA292949-02		Indu Kohaar, Ph.D., M.Phil., M.Sc.
Mugo, Nelly Rwamba	Kenya Medical Research Institute (Kemri) United States	KEMRI-PHRD UG1 CASCADE NETWORK UNIT: CERVICAL CANCER PREVENTION FOR WOMEN LIVING WITH HIV RESEARCH	5UG1CA285132-02		Maria Silvina Frech, Ph.D., M.S.
Muller, Carolyn Y	University Of New Mexico Health Scis Ctr United States	NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites	5UG1CA189856-11		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Mungo, Irene Chemtai	Univ Of North Carolina Chapel Hill United States	Feasibility of artesunate to improve HPV and cervical precancer treatment outcomes among HIV positive women in LMICs	5R34CA284983-02		Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Murenzi, Gad	Research For Development United States	Characterizing women living with HIV at cervical cancer diagnosis in Rwanda: Mentored Research under the Rwanda CASCADE Clinical Trials Site	3UG1CA284908-02S1		Maria Silvina Frech, Ph.D., M.S.
Mustian, Karen M.	University Of Rochester United States	URCC NCORP Research Base	5UG1CA189961-11		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Muzumdar, Mandar Deepak	Yale University United States	Targeting pancreatic endocrine-exocrine signaling in cancer development with incretin mimetics	1R01CA296916-01
Mwesigwa, Betty	Makerere University Walter Reed Project United States	Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Uganda (CASCADE UGANDA)	5UG1CA275412-03		Maria Silvina Frech, Ph.D., M.S.
Nabavi, Sheida	University Of Connecticut Storrs United States	SCH: Robust Multimodal Longitudinal AI for Enhanced Breast Cancer Screening	1R01CA297855-01
Naicker, Nivashnee	Centre/Aids Programme/Res/South Africa United States	CAPRISA CASCADE Clinical Trials Network Clinical Research Site	5UG1CA284671-02		Maria Silvina Frech, Ph.D., M.S.
Nappi, Lucia	Provincial Health Services Authority United States	Integrating investigational miR371a-3p with conventional radiology imaging for earlier and more precise detection of active germ cell malignancy: A BCC/SWOG/S1823 secondary use of data collaboration.	5R37CA264798-03	PAR-19-264 (R01 Clinical Trial Optional)	Guillermo Marquez, Ph.D.
Nath, Kavindra	University Of Pennsylvania United States	Metabolic Biomarkers of Response of Mantle Cell Lymphoma to Bruton Tyrosine Kinase Inhibition	5R01CA228457-05
Nechiporuk, Alex	Oregon Health & Science University United States	High-throughput identification of molecular targets responsible for drug-induced peripheral neuropathies.	1R21CA260025-01A1		Rachel Altshuler, Ph.D.
Nelson, Randy J.	West Virginia University United States	Mechanism Underlying Sleep Disruption by Mammary Tumors	5R21CA276027-02		Marjorie Perloff, M.D.
Neslund-Dudas, Christine Marie	Henry Ford Health + Michigan State University Health Sciences United States	HFH-MSU CSRN ACCrual Enrollment and Screening Site	3UG1CA287007-02S1		Elyse LeeVan, M.D., M.P.H.
Nguyen, Sang Minh	Vanderbilt University Medical Center United States	Gut Microbiome Profiles in Association with Breast Cancer Recurrence and Mortality	1R03CA292953-01		Gabriela Riscuta, M.D., CNS
Nicolson, Fay	Dana-Farber Cancer Inst United States	SESORRS endoscopy for the staging and evaluation of colorectal cancer	5R00CA266921-04
NINA, BHARDWAJ,	ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI United States	Immune determinants modulating cancer development in Lynch Syndrome	1UG3CA290517-01
Noble, Mark D	University Of Rochester United States	Prevention and treatment of paclitaxel-induced peripheral neuropathy	5R21CA277447-02		Rachel Altshuler, Ph.D.
Nolan, Michael Warren	North Carolina State University Raleigh United States	Evaluation of TRPM8-expressing neurons as novel regulators of acute radiotherapy-associated pain in patients with head and neck cancer	5R37CA248797-05		Asad Umar, D.V.M., Ph.D.
Nyamathi, Adeline M	University Of California-Irvine United States	Secondary Cervical Cancer Prevention of Vulnerable Women with HPV and HIV Co-infection in India	5R01CA285063-02		Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Oberg, Ann Laura	Mayo Clinic Rochester United States	Management and Data Coordination Unit for PCDC	5U24CA274496-03		Guillermo Marquez, Ph.D.
Ochoa, Augusto C.	Lsu Health Sciences Center United States	Gulf South Minority/Underserved Clinical Trials Network (Gulf South M/U CTN)	5UG1CA189854-11		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Olopade, Olufunmilayo F.	University Of Chicago United States	Chicago Alternative Prevention Study for BReast CAncer in Diverse Populations of High-Risk Women (CAPSBRACA)	5R01CA276652-02		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Ondrey, Frank G.	University Of Minnesota United States	Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia	5R01CA254270-03	PAR-21-035 (R01 Clinical Trial Required)	Malgorzata Wojtowicz, M.D.
Onitilo, Adedayo A	Marshfield Clinic Research Foundation United States	Wisconsin NCI Community Oncology Research Program (WiNCORP)	5UG1CA189956-11		Vanessa A. White, M.P.H.
Osarogiagbon, Raymond U	Baptist Memorial Hospital - Tipton United States	Baptist Memorial Health Care/Mid South NCORP Minority Underserved Consortium	5UG1CA189873-11		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Oskeritzian, Carole A	University Of South Carolina At Columbia United States	Novel modalities for prostate cancer screening: mast cells as predictors of disease, disease aggressiveness and marks of disease disparity	5R21CA274021-02		Guillermo Marquez, Ph.D.
Oskeritzian, Carole A	University Of South Carolina At Columbia United States	Development of a noninvasive, rapid and affordable method for early detection of colorectal cancer	5R21CA245651-03		Matthew Young, Ph.D.
Palefsky, Joel Michael	University Of California, San Francisco United States	California-Mexico-Puerto Rico Partnership (CAMPO) Center for Prevention of HPV-related Cancer in HIV+ Populations	5U54CA242646-06		Maria Silvina Frech, Ph.D., M.S.
Palesh, Oxana G	Virginia Commonwealth University United States	Multicenter Randomized Controlled Trial of Brief Behavioral Therapy for Cancer Related Insomnia	5R01CA239714-07		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Panda, Satchidananda	Salk Institute For Biological Studies United States	Impact of Time-Restricted Feeding in Reducing Cancer Risk Through Optimizing Mitochondria Function	5R01CA258221-04	RFA-CA-20-004 (R01 Clinical Trial Optional)	Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Pandharipande, Pari Vijay	Ohio State University United States	Precision Management of Cystic Precursors to Pancreatic Cancer	5R01CA237133-06		Matthew Young, Ph.D.
Panigrahy, Dipak	Beth Israel Deaconess Medical Center United States	Control of cancer cachexia via stimulation of resolution of inflammation	5R01CA276107-02		Marjorie Perloff, M.D.
Panikkar, Rajiv	Geisinger Clinic United States	Geisinger Cancer Institute - NCI Community Oncology Research Program (NCORP)	5UG1CA189847-11		Vanessa A. White, M.P.H.
Papachristodoulou, Alexandros	Rutgers Biomedical And Health Sciences United States	Investigating mitochondrial dysfunction in high-risk prostate cancer	4R00CA276713-03		Vignesh Gunasekharan, Ph.D.
Papadopoulos, Nickolas	Johns Hopkins University United States	Multi-analyte Approach for Earlier Detection of Cancers in Non Plasma Biofluids	5U01CA230691-07
Park, Youngkyu	Cold Spring Harbor Laboratory United States	Preclinical Models for Cancer Therapeutic Development	5R50CA211506-09		Marjorie Perloff, M.D.
Paskett, Electra D.	Alliance Nctn Foundation United States	Alliance NCORP Research Base - BIQSFP GY11 Supplements	3UG1CA189823-11S2		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Patel, Abhijit	Yale University United States	Lung Cancer Screening via Ultrasensitive and Cost-efficient Analysis of Tumor DNA Signatures in Blood	5U01CA233364-05		Nick Hodges, Ph.D.
Paulovich, Amanda G	Fred Hutchinson Cancer Center United States	Breast-cancer focused biomarker characterization center employing targeted mass spec assays in a CLIA environment	5U2CCA271873-03		Sidney Fu, M.D.
Paulson, Thomas G	Fred Hutchinson Cancer Center United States	The microbiome ecosystem of Barrett's esophagus and progression to cancer	5R21CA259687-02	PAR-20-292 (R21 Clinical Trial Optional)	Matthew Young, Ph.D.
Paus, Ralf	University Of Miami School Of Medicine United States	Pre-clinical testing of low intensity ultrasound as novel strategy to prevent paclitaxel-induced hair follicle damage in a humanized mouse model of chemotherapy-induced alopecia	1R21CA277418-01A1		Rachel Altshuler, Ph.D.
Pena, Maria Marjorette	University Of South Carolina At Columbia United States	The Role of Early Life Exposure to Antibiotics on Risk of Early Onset Colorectal Cancer	1R21CA281729-01A1
Peppone, Luke Joseph	University Of Rochester United States	High-dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients	5R01CA258349-04		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Perkins, Susan M	Indiana University Indianapolis United States	Evaluation of the Communication Plan Early through End-of-Life (COMPLETE) Intervention	5R01CA235632-06		Brennan Streck, Ph.D., RN, M.P.H.
Perlis, Michael Lloyd	University Of Pennsylvania United States	The Association Between CBT-I Dose, Sleep Duration, and Fatigue in Breast Cancer Patients	1R21CA270987-01	PAR-20-292 (R21 Clinical Trial Optional)	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Permuth, Jennifer B.	H. Lee Moffitt Cancer Ctr & Res Inst United States	Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Uncover Hidden Biology	4R37CA229810-06		Matthew Young, Ph.D.
Peters, Jeffrey M	Pennsylvania State University, The United States	Unique targeting of PPARβ/δ regulation for cancer prevention and therapy	5R01CA239256-05		Marjorie Perloff, M.D.
Phillips, Nicholas S	St. Jude Children'S Research Hospital United States	Cardiopulmonary function and cerebral blood flow in Hodgkin Lymphoma survivors	5R21CA280230-02		Eileen Dimond, R.N., M.S.
Pinder, Leeya F	University Of Cincinnati United States	RepurPosed AntiretrOviraL ThErapieS to EliminAte Cervical Cancer (POLESA Trial)	5R37CA284033-02		Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Pistilli, Emidio Edward	West Virginia University United States	Targeting Muscle Fatigability During Cachexia	5R01AR079445-04		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Pitteri, Sharon	Stanford University United States	Glycosylation and Immune Evasion in Urologic Tumors	5U01CA226051-05		Richard Mazurchuk, Ph.D.
Plas, Ellen Van Der	Arkansas Children'S Hospital Res Inst United States	Identifying markers of abnormal neurocognitive trajectories during chemotherapy treatment of childhood acute lymphoblastic leukemia	5R37CA266135-03	PA-20-185 (Parent R01 Clinical Trial Not Allowed)	Asad Umar, D.V.M., Ph.D.
Pollack, Alan	University Of Miami School Of Medicine United States	MRI Imaging and Biomarkers for Early Detection of Aggressive Prostate Cancer	5U01CA239141-05		Richard Mazurchuk, Ph.D.
Porter, Laura S	Duke University United States	Couple Communication Skills Training for Advanced Cancer	5R01CA229425-05		Brennan Streck, Ph.D., RN, M.P.H.
Pozdeyev, Nikita	University Of Colorado Denver United States	Genetic architecture of thyroid cancer and its clinical utility	1R21CA282380-01A1		Wendy Wang, Ph.D., M.Sc.
Prigerson, Holly Gwen	Weill Medical Coll Of Cornell Univ United States	Behavioral and Psychosocial Effects on Study Outcomes in End-Stage Cancer Treatment (BEST End-Stage Cancer Study)	5R35CA197730-10		Brennan Streck, Ph.D., RN, M.P.H.
Punnen, Sanoj	University Of Miami School Of Medicine United States	The Rigor and Clinical Utility of PSMA Enriched Extracellular Vesicles for Prostate Cancer Detection	5R01CA272766-02		Matthew Young, Ph.D.
Pyter, Leah M	Ohio State University United States	Chemotherapy-induced circadian master clock disruptions and fatigue	3R01CA270372-03S1	PA-20-185 (Parent R01 Clinical Trial Not Allowed)	Marjorie Perloff, M.D.
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-11
Ramanujam, Nirmala	Duke University United States	Development and Validation of an Artificial-Intelligence-enabled Portable Colposcopy Device for Optimizing Triage Alternatives for HPV-based Cervical Cancer Screening	5U01CA269192-03		Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Rao, Chinthalapally V.	University Of Oklahoma Hlth Sciences Ctr United States	Discovery and Development of Natural Products for Interception of CRC	5UG3CA290310-02		Kajal Biswas, Ph.D.
Rapaport, Mark Hyman	University Of Utah United States	Massage for Prostate Cancer-Related Fatigue	1R21CA263453-01	PAR-20-292 (R21 Clinical Trial Optional)	Goli Samimi, Ph.D., M.P.H.
Reb, Anne	Beckman Research Institute/City Of Hope United States	A Blended e-Health Intervention for Fear of Progression in Advanced GYN Cancer	1R21CA293326-01		Brennan Streck, Ph.D., RN, M.P.H.
Reese, Jennifer Barsky	Research Inst Of Fox Chase Can Ctr United States	Promoting Effective Clinical Communication about Sexual Health after Gynecologic Cancer: A Randomized Controlled Trial of a Patient-Focused Intervention	1R01CA285674-01A1
Remick, Scot C	Mainehealth United States	MaineHealth Cancer Care Network (MHCCN) and NCORP Activities across the Lifespan	5UG1CA239771-06		Vanessa A. White, M.P.H.
Reuland, Daniel S.	Univ Of North Carolina Chapel Hill United States	Administrative Supplement: CSRN Vanguard Study	3UG1CA286949-02S1		Elyse LeeVan, M.D., M.P.H.
Richards-Kortum, Rebecca R.	Rice University United States	Low-cost mobile colposcopy and confocal imaging for global prevention of cervical cancer	5R01CA251911-05		Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Richards-Kortum, Rebecca R.	Rice University United States	Sample-to-answer HPV DNA nucleic acid test for cervical cancer screening in Mozambique	1U01CA292741-01		Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Rini, Christine	Northwestern University At Chicago United States	Mosaic: RCT of a Digital Health Intervention Delivering Peer Support Narratives and Psychoeducation to English- and Spanish-Speaking Stem Cell Transplant Recipients	1R01CA292116-01		Brennan Streck, Ph.D., RN, M.P.H.
Rini, Christine	Northwestern University At Chicago United States	Web-based Pain Coping Skills Training to Improve Pain and Poor Adherence caused by Aromatase Inhibitor-Associated Arthralgia In Breast Cancer Survivors (SKIP-Arthralgia): A Randomized Controlled Trial	5R01CA271220-03		Brennan Streck, Ph.D., RN, M.P.H.
Robbins, Hilary A.	International Agency For Res On Cancer United States	The Lung EArly Proteins project: A LEAP toward implementing biomarkers in lung cancer screening	5R01CA262164-03		Claire Zhu, Ph.D.
Robertson, Gavin P.	Pennsylvania State Univ Hershey Med Ctr United States	Targeting Aldehyde Dehydrogenase for Cancer Prevention	5R01CA241148-05
Rogers, Laura Q	University Of Alabama At Birmingham United States	Role of gut microbe composition in psychosocial symptom response to exercise training in breast cancer survivors	5R01CA235598-06		Gabriela Riscuta, M.D., CNS
Rosenberg, Daniel William	University Of Connecticut Sch Of Med/Dnt United States	Microbiota, Metabolites, and Colon Neoplasia	5R01CA252045-05		Amit Kumar, Ph.D.
Rosenberg, Abby R	Dana-Farber Cancer Inst United States	The Promoting Resilience in Stress Management (PRISM) Intervention: a multi-site randomized controlled trial for Adolescents and Young Adults with advanced cancer	7R01CA222486-06		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Rosenbluth, Jennifer M.	University Of California, San Francisco United States	In vitro models as a window to learn how to change outcomes in women at high risk of developing breast cancer	5R01CA281361-03		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Ross, Stephen	New York University School Of Medicine United States	Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress	5R01CA268521-03		Rachel Altshuler, Ph.D.
Rosser, Charles J	Cedars-Sinai Medical Center United States	A Multiplex Protein Biomarker-Based Immunoassay for the Early Detection of Bladder Cancer and its Implications in Tumor Biology	5R01CA277810-03		Guillermo Marquez, Ph.D.
Rotemberg, Veronica Miriam	Sloan-Kettering Inst Can Research United States	M-ISIC: A Multimodal Open-Source International Skin Imaging Collaboration Informatics Platform for Automated Skin Cancer Detection	5U24CA264369-03		Guillermo Marquez, Ph.D.
Roth, Michael E.	Public Health Institute United States	Children's Oncology Group NCI Community Oncology Research Program (NCORP) Research Base grant	3UG1CA189955-11S2		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Rowland, Kendrith Martin	Carle Foundation United States	Carle Cancer Center NCI Community Oncology Research Program (NCORP)	5UG1CA189861-11		Vanessa A. White, M.P.H.
Russell, John A	University Of Wisconsin-Madison United States	Treatment of Functional Deficits IN tongue muscles induced by radiation and chemoradiation treatment	5R37CA225608-07		Cecilia Lee, Dr.P.H., RN
Saenger, Yvonne Margaret	Albert Einstein College Of Medicine United States	Applying pathomics to establish a biosignature for aggressive skin melanoma	5R01CA260375-04		Guillermo Marquez, Ph.D.
Salami, Simpa Samuel	University Of Michigan At Ann Arbor United States	Defining the Biological Arc of Grade Group 1 Prostate Cancer	5R37CA283857-02		Guillermo Marquez, Ph.D.
Salkowski, Lonie	University Of Wisconsin-Madison United States	Defining and Optimizing Critical Interpretation Skills in Screening Mammography to Improve Cancer Detection	5R37CA262110-04		Guillermo Marquez, Ph.D.
Salman, Emad	Florida Assn Of Pediatric Tumor Prog United States	The Florida Pediatric NCORP renewal application for grant# UG1CA189973 to continue participation in the NCI Community Oncology Research Program.	5UG1CA189973-11		Vanessa A. White, M.P.H.
Salvemini, Daniela	Saint Louis University United States	A3AR agonists as a novel approach to mitigate chemotherapy induced neurotoxicity	5R01CA230512-05		Rachel Altshuler, Ph.D.
Salvemini, Daniela	Saint Louis University United States	Fingolimod and Ozanimod for the treatment and prevention of chemobrain	5R01CA261979-03		Rachel Altshuler, Ph.D.
Sanchez, Eduardo Vilar	University Of Tx Md Anderson Can Ctr United States	Cancer Immune-Interception in a Spontaneous Non-Human Primate Model of Lynch Syndrome	5R01CA260761-03		Asad Umar, D.V.M., Ph.D.
Sanchez, Eduardo Vilar	University Of Tx Md Anderson Can Ctr United States	iCAN-PREVENT: MD Anderson International Cancer Prevention Clinical Trial Consortium	5UG1CA242609-06		Donald Johnsey
Sanchez, Eduardo Vilar	University Of Tx Md Anderson Can Ctr United States	Cancer Immune-Interception for Lynch Syndrome	5R01CA257375-04		Asad Umar, D.V.M., Ph.D.
Sanda, Martin G	Emory University United States	Prostate Cancer Biomarker and Imaging Validation Alliance: Emory University, University of Alabama Birmingham, and University of Texas Southwestern	5U01CA113913-17		Indu Kohaar, Ph.D., M.Phil., M.Sc.
Sands, Stephen Alan	Sloan-Kettering Inst Can Research United States	Prospective international phase-III study to improve neurocognitive outcomes in young children with low-risk medulloblastoma (YCMB-LR)	5R01CA283045-02	PAR-21-329 (R01 Clinical Trial Optional)	Marjorie Perloff, M.D.
Sant, Shilpa	University Of Illinois At Chicago United States	Three-dimensional organoid models to study breast cancer progression	5R37CA232209-07		Guillermo Marquez, Ph.D.
Santomasso, Bianca Denise	Sloan-Kettering Inst Can Research United States	Comprehensive Molecular and Clinical Characterization of Acute and Chronic Neurotoxicity Following CAR-T Cell Therapy	1R01CA293922-01		Monica Epstein, B.S.N., RN, OCN
Santos-Reyes, Luis Javier	Comprehensive Cancer Center/ Univ/Pr United States	Puerto Rico Minority Underserved NCI Community Oncology Research Program (Puerto Rico MUNCORP)	5UG1CA189862-11		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Saphner, Thomas J	Aurora Health Care, Inc. United States	Aurora NCORP Community Site	5UG1CA190140-11		Vanessa A. White, M.P.H.
Sariol, Carlos A	University Of Puerto Rico Med Sciences United States	SARS-CoV-2 correlates of protection in a Latino-origin population	3U01CA260541-02S2		Guillermo Marquez, Ph.D.
Schallenkamp, John M.	Montana Cancer Consortium United States	Montana Cancer Consortium: An Inclusive and Collaborative Approach to Clinical Trial Accrual and Cancer Care Delivery Research across Montana, Idaho and Wyoming	5UG1CA189872-11		Vanessa A. White, M.P.H.
Schaverien, Mark V	University Of Tx Md Anderson Can Ctr United States	Lymphedema Prevention Through Immediate Lymphatic Reconstruction	1R01CA292908-01		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Schedin, Pepper J	Oregon Health & Science University United States	NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention	5R01CA169175-11		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Schenker, Yael	University Of Pittsburgh At Pittsburgh United States	Patient-centered and efficacious advance care planning in cancer: the PEACe comparative effectiveness trial	5R01CA235730-06		Brennan Streck, Ph.D., RN, M.P.H.
Schmidt, Christian Maximillian	Indiana University Indianapolis United States	Longitudinal Proteomic and Metabolomic Predictors of Pancreatic Cyst Malignant Progression and Early Stage Pancreatic Cancer	5U01CA239522-05		Claire Zhu, Ph.D.
Schmit, Stephanie L.	Cleveland Clinic Lerner Com-Cwru United States	Investigation of within-Latino heterogeneity in colorectal cancer mutational and T cell profiles	3R01CA248931-04S1		Asad Umar, D.V.M., Ph.D.
Schoen, Robert E.	University Of Pittsburgh At Pittsburgh United States	Blood-Based Testing for Advanced Adenoma	5U01CA271884-03		Matthew Young, Ph.D.
Schroeck, Florian R	Veterans Education/Res/Assn/North/Ne United States	Replacing Invasive Cystoscopy with Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance	5R37CA275916-02		Claire Zhu, Ph.D.
Schuetze, Scott Michael	University Of Michigan At Ann Arbor United States	Early Phase Clinical Cancer Prevention Consortium	5UG1CA242632-05		Donald Johnsey
Sears, Rosalie C	Oregon Health & Science University United States	An atlas of pancreatic tumorigenesis in the context of altered DNA repair occurring in high-risk individuals	1U01CA294548-01		Indu Kohaar, Ph.D., M.Phil., M.Sc.
Sears, Rosalie C	Oregon Health & Science University United States	Validation of novel imaging and molecular tests for early detection of pancreatic cancer through risk-stratified community engagement programs	5U01CA278923-03	PAR-21-334 (U01 Clinical Trial Optional)	Matthew Young, Ph.D.
Sedrak, Mina S	University Of California Los Angeles United States	Using Senolytics to Improve Physical Function in Older Breast Cancer Survivors	5R21CA277660-03		Goli Samimi, Ph.D., M.P.H.
Sedrak, Mina S	University Of California Los Angeles United States	Targeting Senescence to Mitigate Chemotherapy-induced Functional Decline	5R01CA280088-02		Goli Samimi, Ph.D., M.P.H.
Segal, Leopoldo Nicolas	New York University School Of Medicine United States	Microbial and host biomarker development for detection and prognosis of early stage non-small cell lung cancer	5U2CCA271890-03		Guillermo Marquez, Ph.D.
Segata, Nicola	University Of Trento United States	PROSPECT - Microbiome Studies. (PATHWAYS, RISK FACTORS, AND MOLECULES TO PREVENT EARLY-ONSET COLORECTAL TUMOURS)	1OT2CA297205-01		Asad Umar, D.V.M., Ph.D.
Semmes, Oliver John	Old Dominion University United States	Virginia-UCLA-Toronto Biomarker Characterization Center	5U2CCA271894-04		Indu Kohaar, Ph.D., M.Phil., M.Sc.
Sempere, Lorenzo	Michigan State University United States	Image-Guided Intraductal Ablative Procedure for Primary Prevention of Breast Cancer	5R01CA258314-04		Edward Sauter, M.D., Ph.D.
Sen, Subrata	University Of Tx Md Anderson Can Ctr United States	Circulating Biomarkers and Imaging for Early Detection of Pancreatic Cancer	2U01CA214263-06		Matthew Young, Ph.D.
Shah, Sohrab P	Sloan-Kettering Inst Can Research United States	Exploiting markers of genomic instability in high-risk pre-invasive ovarian cancer	5R01CA281928-03		Christos Patriotis, Ph.D., M.Sc.
Shain, Alan Hunter	University Of California, San Francisco United States	Pre-cancer atlas of skin cancer	1U01CA294536-01		Nick Hodges, Ph.D.
Shalon, Tidhar Dari	Envivo Bio Inc United States	Development and clinical evaluation of the CapScan gastrointestinal sampling device for metabolomics monitoring	5R33CA260665-03		Amit Kumar, Ph.D.
Shelby, Rebecca A	Duke University United States	Persistent Post-Mastectomy Pain: Randomized Clinical Trial of Targeted Pain Coping Skills Training (Targeted-PCST) with Mediational Analysis	5R01CA249959-05		Brennan Streck, Ph.D., RN, M.P.H.
Shen, Chan	Pennsylvania State Univ Hershey Med Ctr United States	The effects of hydrocodone rescheduling on pain management of older lung cancer patients	1R21CA277849-01		Rachel Altshuler, Ph.D.
Shiozawa, Yusuke	Wake Forest University Health Sciences United States	Contribution of cutaneous neuro-immune interactions to chemotherapy-induced peripheral neuropathy	1R21CA297068-01		Rachel Altshuler, Ph.D.
Shirwan, Haval	University Of Missouri-Columbia United States	Developing a novel agonist of CD137 for cancer immunoprevention	1UG3CA290305-01		Altaf Mohammed, Ph.D.
Shu, Xiao-Ou	Vanderbilt University Medical Center United States	Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer	5R01CA227133-05		Matthew Young, Ph.D.
Shuck, Sarah C.	Beckman Research Institute/City Of Hope United States	Identification of metabolic adducts associated with prostate cancer progression in African American men Supplement	3R21CA282612-01S1		Guillermo Marquez, Ph.D.
Shureiqi, Imad	University Of Michigan At Ann Arbor United States	ALOX15 regulation of colon cancer invasiveness via PI3P-linoleic acid metabolism	5R01CA266223-04		Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Siddique, Shahzad	Commonspirit Health Research Institute United States	CIRI Oncology Research Alliance	5UG1CA189809-11		Vanessa A. White, M.P.H.
Sidransky, David	Johns Hopkins University United States	Racial differences in Immunogenetic Tumorigenesis of Head and Neck Squamous Cell Carcinoma	5R01CA265975-03		Wendy Wang, Ph.D., M.Sc.
Sieren, Jessica C	University Of Iowa United States	Lung cancer screening efficacy enhanced through radiomic and epigenetic biomarkers	5R01CA267820-03
Sigel, Keith Magnus	Icahn School Of Medicine At Mount Sinai United States	The effectiveness of screening women with lower genital tract neoplasia or cancers for anal cancer precursors	5R01CA256660-04		Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Simeone, Diane M	University Of California, San Diego United States	Biomarker Validation in Pancreatic Cystic Neoplasms	7U01CA282272-02	PAR-21-334 (U01 Clinical Trial Optional)	Matthew Young, Ph.D.
Siminski, Suzanne M.	Frontier Sci & Technology Rsch Fdn, Inc United States	CASCADE Coordinating Center	5U24CA275417-03		Maria Silvina Frech, Ph.D., M.S.
Singal, Amit	Ut Southwestern Medical Center United States	Precision Risk Stratification and Screening for HCC among Patients with Indeterminate Liver Nodules	5U01CA283935-02		Sidney Fu, M.D.
Singal, Amit	Ut Southwestern Medical Center United States	Precision Risk Stratification and Screening for HCC among Patients with Cirrhosis in the United States	5U01CA230694-05
Singal, Amit	Ut Southwestern Medical Center United States	Clinical Validation Center for Hepatocellular Carcinoma	5U01CA271887-03		Indu Kohaar, Ph.D., M.Phil., M.Sc.
Singal, Amit	Ut Southwestern Medical Center United States	Precision Screening for Hepatocellular Carcinoma in Patients with Cirrhosis	5R01CA222900-06
Skates, Steven J	Massachusetts General Hospital United States	Genome-wide methylation and proteomic analysis of uterine lavage and cervical swab for early detection of ovarian cancer	5U2CCA271871-02		Christos Patriotis, Ph.D., M.Sc.
Skates, Steven J	Massachusetts General Hospital United States	Proteomic Analyses of Serial Prediagnostic PLCO Serum in Cases and Controls to Identify Early Detection Ovarian Cancer Biomarkers Rising in a Substantial Fraction of Cases and Stable in Most Controls	5U01CA260758-04	PAR-18-913 (U01 Clinical Trial Not Allowed)	Claire Zhu, Ph.D.
Skubitz, Amy Patrice	University Of Minnesota United States	A paradigm shift for ovarian cancer biomarkers: Utilizing routine Pap tests as liquid biopsies for the development of targeted mass spectrometry-based proteomic assays for early detection	5R01CA262153-04	PA-20-185 (Parent R01 Clinical Trial Not Allowed)	Christos Patriotis, Ph.D., M.Sc.
Slager, Susan L	Mayo Clinic Rochester United States	The genetic and epigenetic etiology of progression from the precursor state to chronic lymphocytic leukemia (CLL)	5R01CA258465-03
Smith, Jennifer Susan	Univ Of North Carolina Chapel Hill United States	UNC CASCADE Network Research Base	5UG1CA275403-03		Maria Silvina Frech, Ph.D., M.S.
Smith, Ellen Mary Lavoie	University Of Alabama At Birmingham United States	Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study	5R01CA235726-07		Brennan Streck, Ph.D., RN, M.P.H.
Sohl, Stephanie Jean	Wake Forest University Health Sciences United States	REmotely-delivered Supportive Programs for Improving surgical pain and disTrEss (RESPITE)	5R01CA266995-03	PAR-21-035 (R01 Clinical Trial Required)	Goli Samimi, Ph.D., M.P.H.
Somers, Tamara J	Duke University United States	A Mobile Health Behavioral Pain Intervention Protocol for Breast Cancer Patients with Pain in Medically Underserved Communities: A Randomized Controlled Trial	5R01CA237892-05		Brennan Streck, Ph.D., RN, M.P.H.
Song, Ming	University Of Louisville United States	Dietary fructose and NASH/HCC progression	5R21CA290420-02		Amit Kumar, Ph.D.
Soragni, Alice	University Of California Los Angeles United States	Targeting p53 conformational defects to arrest carcinogenesis	5R01CA240718-05		Goli Samimi, Ph.D., M.P.H.
Sorror, Mohamed	Fred Hutchinson Cancer Center United States	Novel Intervention Approaches to Alleviate Allogeneic Transplant-Related Morbidity and Mortality	5R01CA227092-06		Marjorie Perloff, M.D.
Spector, Tim	King'S College London United States	PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors	1OT2CA297289-01		Asad Umar, D.V.M., Ph.D.
Spiegel, Brennan	Cedars-Sinai Medical Center United States	Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes	5R01CA252211-05		Rachel Altshuler, Ph.D.
Spira, Avrum E	Boston University Medical Campus United States	The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy	1U2CCA233238-01		Richard Mazurchuk, Ph.D.
Stachler, Matthew D	University Of California, San Francisco United States	Optimization and validation of a biomarker panel for risk stratification in Barrett's esophagus	3R37CA269649-03S1	PA-20-185 (Parent R01 Clinical Trial Not Allowed)	Matthew Young, Ph.D.
Staff, Nathan P	Mayo Clinic Rochester United States	Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity	5R01CA275870-03	PAR-21-329 (R01 Clinical Trial Optional)	Rachel Altshuler, Ph.D.
Stolley, Melinda R	Medical College Of Wisconsin United States	Every Day Counts: A lifestyle program for women metastatic breast cancer	5R01CA258759-04	PAR-18-893 (R01 Clinical Trial Optional)	Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Stolley, Melinda R	Medical College Of Wisconsin United States	Men Moving Forward: A Lifestyle Intervention for African American Prostate Cancer Survivors	3R01CA229546-05S1
Storz, Peter	Mayo Clinic Jacksonville United States	Deiminated molecules as markers for developing pancreatic cancer - A1	5R21CA279916-02		Matthew Young, Ph.D.
Suga, Jennifer Marie	Kaiser Foundation Research Institute United States	Kaiser Permanente NCI National Community Oncology Research Program, NCORP	5UG1CA189821-11		Vanessa A. White, M.P.H.
Sukumar, Saraswati	Johns Hopkins University United States	Development of an automated, point of care DNA methylation cartridge blood test for colorectal cancer detection in LMICs- an academic-industrial partnership	5R01CA278816-03		Matthew Young, Ph.D.
Sun, Ju	University Of Minnesota United States	SCH: A New Computational Framework for Learning from Imbalanced Biomedical Data	5R01CA287413-02
Suter, Melissa J	Massachusetts General Hospital United States	Early Detection and Diagnosis of Lung Cancer with Endomicroscopy	5R01CA255326-03		Guillermo Marquez, Ph.D.
Svatek, Robert Scott	University Of Texas Hlth Science Center United States	eRapa for bladder cancer prevention	5R01CA252057-05	PAR-19-183 (R01 Clinical Trial Optional)	Howard L. Parnes, M.D.
Tabung, Fred Kinyuy	Ohio State University United States	Role of the inflammatory dietary pattern in gut and colon tissue microbiomes and impact on survival outcomes among colorectal cancer patients	1R21CA294050-01		Amit Kumar, Ph.D.
Tamkus, Deimante	Cook County Health And Hospital System United States	Stroger Hospital of Cook County (SHCC) MU-NCORP	7UG1CA190000-12		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Tamrazi, Benita	Children'S Hospital Of Los Angeles United States	Brain iron accumulation as an in vivo quantifiable biomarker of neurocognitive dysfunction in pediatric brain tumor survivors	5R21CA262978-02		Rachel Altshuler, Ph.D.
Tanasova, Marina	Michigan Technological University United States	Molecular probes for targeting facilitative fructose transporters (GLUTs) in biochemical and biomedical applications	2R15CA242401-02A1		Wendy Wang, Ph.D., M.Sc.
Tangen, Catherine M.	Fred Hutchinson Cancer Center United States	PCPT and SELECT Cohorts: Core Infrastructure Support for Cancer Research	5U01CA182883-11		Howard L. Parnes, M.D.
Taouli, Bachir	Icahn School Of Medicine At Mount Sinai United States	Abbreviated MRI for HCC screening in cirrhotic patients	5R01CA249765-05		Guillermo Marquez, Ph.D.
Taratula, Oleh	Oregon State University United States	Novel Nanomedicine-Based Therapeutic Approach For Treatment of Cancer Cachexia	5R37CA234006-07		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Tayob, Nabihah	Dana-Farber Cancer Inst United States	Biomarker screening algorithms for the improved early detection of hepatocellular carcinoma	5R01CA230503-07
Tearney, Guillermo J	Massachusetts General Hospital United States	Colorectal Cancer Screening with Optical Coherence Tomography	1R01CA280972-01A1		Matthew Young, Ph.D.
Temprosa, Marinella	George Washington University United States	22/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) – Biostatistics Center	2U01DK048489-28		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Tennis, Meredith A	University Of Colorado Denver United States	Persistence and regression in lung premalignant lesions	1R01CA289576-01A1		Malgorzata Wojtowicz, M.D.
Tennis, Meredith A	University Of Colorado Denver United States	Modeling lung squamous cell carcinoma premalignancy and prevention	1R01CA298925-01
Terry, Kathryn L.	Brigham And Women'S Hospital United States	Changing Contraceptive Patterns and Ovarian Cancer Risk	5R01CA258679-05	PA-20-185 (Parent R01 Clinical Trial Not Allowed)	Goli Samimi, Ph.D., M.P.H.
Tewari, Ashutosh K	Icahn School Of Medicine At Mount Sinai United States	Artificial intelligence enabled Stroma-Weighted Automated Grading system to improve risk stratification in Black Men	1R01CA290438-01A1		Indu Kohaar, Ph.D., M.Phil., M.Sc.
Thakur, Mathew Laxman	Thomas Jefferson University United States	Noninvasive, Uniplex, Molecular, Pathomic Urinary Assay for Detection of Prostate Cancer	5R01CA249921-05		Richard Mazurchuk, Ph.D.
Thangaraju, Muthusamy	Augusta University United States	Bacteria-derived xenobiotics in colon cancer prevention: Link to GPR109A and colonic ketogenesis	5R01CA275840-02
Thompson, Patricia Ann	State University New York Stony Brook United States	Three-Arm randomized trial comparing the effect of aspirin, sulindac or no treatment control on breast density in patients with elevated breast cancer risk	5R01CA235720-05		Edward Sauter, M.D., Ph.D.
Thompson, Patricia Ann	University Of Arizona United States	University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet)	5UG1CA242596-06		Donald Johnsey
Tighiouart, Mourad	Cedars-Sinai Medical Center United States	Advancing Analysis and Interpretation of Adverse Events and PROs in Cancer Clinical Trials	3U01CA232859-05S1		Rachel Altshuler, Ph.D.
Tollefsbol, Trygve O	University Of Alabama At Birmingham United States	Combinatorial epigenetic-based prevention of breast cancer	5R01CA178441-10		Gabriela Riscuta, M.D., CNS
Tong, Frank	Vanderbilt University United States	Learning the visual and cognitive bases of lung nodule detection	5R01CA240274-05		Richard Mazurchuk, Ph.D.
Toriola, Adetunji T	Washington University United States	Targeting RANK Pathway in Mammographic Density and Primary Breast Cancer Prevention	4R37CA235602-06		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Torres, Keila Enitt	University Of Tx Md Anderson Can Ctr United States	Use of Noninvasive Biomarkers and Advanced MRI for early detection of NF1-associated MPNSTs	5R01CA285980-02		Guillermo Marquez, Ph.D.
Tussing-Humphreys, Lisa	University Of Illinois At Chicago United States	Effects of Time-restricted Eating versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers among Adults with Obesity	3R01CA257807-04S1		Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Ulrich, Cornelia M	University Of Utah United States	Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link	5R01CA254108-04		Asad Umar, D.V.M., Ph.D.
V, DHODAPKAR, MADHAV	EMORY UNIVERSITY United States	Targeting microbial triggers of gammopathy for immunoprevention	1UG3CA290302-01
Valdimarsdottir, Heiddis	Icahn School Of Medicine At Mount Sinai United States	Systematic Light Exposure Effects on Circadian Rhythms Entrainment, Inflammation, Neutropenic Fever and Symptom Burden among Multiple Myeloma Patients undergoing Autologous Stem Cell Transplantation	5R01CA260961-03	PAR-21-035 (R01 Clinical Trial Required)	Marjorie Perloff, M.D.
Velculescu, Victor E.	Johns Hopkins University United States	DNA evaluation of fragments for early interception (DELFI) of Lung cancer	5U01CA271896-02		Guillermo Marquez, Ph.D.
Villanueva, Augusto	Icahn School Of Medicine At Mount Sinai United States	Liquid biopsy and radiomics for liver cancer surveillance	5U01CA283931-02		Sidney Fu, M.D.
Vinciguerra, Vincent P	Feinstein Institute For Medical Research United States	Northwell Health NCORP	3UG1CA189850-11S1		Vanessa A. White, M.P.H.
Wagner, Lynne I.	Ecog-Acrin Medical Research Foundation United States	ECOG-ACRIN NCORP Research Base	5UG1CA189828-11		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Wallace, Douglas C	Children'S Hosp Of Philadelphia United States	Anti-tumor immunity and intestinal microbiota are modulated by mitochondrial DNA	5R01CA259635-04		Young Kim, Ph.D.
Wang, Thomas D	University Of Michigan At Ann Arbor United States	Peptide multimer for early detection of hepatocellular carcinoma	1R01CA285303-01A1		Guillermo Marquez, Ph.D.
Wang, Thomas D	University Of Michigan At Ann Arbor United States	Early detection of colorectal cancer in the traditional and serrated pathways	5R01CA249851-05		Guillermo Marquez, Ph.D.
Wang, Tza-Huei Jeff	Johns Hopkins University United States	A low-cost, multiplexed digital high resolution melt platform for DNA methylation-based detection and identification of cancers in liquid biopsies	5R33CA272321-03		Christos Patriotis, Ph.D., M.Sc.
Wang, Linghua	University Of Tx Md Anderson Can Ctr United States	Center for Gastric Pre-Cancer Atlas of Multidimensional Evolution in 3D (GAME3D)	1U01CA294518-01		Indu Kohaar, Ph.D., M.Phil., M.Sc.
Wang, Jing	New York University School Of Medicine United States	Optimizing the use of ketamine to reduce chronic postsurgical pain	3UH3CA261067-05S1		Brennan Streck, Ph.D., RN, M.P.H.
Wang, Tza-Huei Jeff	Johns Hopkins University United States	Development of a low-cost epigenetic screening assay for Pap specimen-based detection of early-stage ovarian cancer in high-risk women	5R01CA260628-05		Christos Patriotis, Ph.D., M.Sc.
Wang, Hsiao-Lan	University Of Alabama At Birmingham United States	A Motion Exergaming Approach to Promote Self-Managing Fatigue and Pain after Head and Neck Cancer Treatment	5R01CA244947-06		Goli Samimi, Ph.D., M.P.H.
Warner, Erica T	Massachusetts General Hospital United States	Aspirins legacy on cancer and overall benefit: risk balance over a 15-year horizon	1U01CA301988-01		Asad Umar, D.V.M., Ph.D.
Washington, Karla	Washington University United States	Problem-Solving Therapy for Cancer Caregivers: A Randomized Clinical Trial in Outpatient Palliative Care	5R01CA258311-04		Brennan Streck, Ph.D., RN, M.P.H.
Watt, Gordon Patrick	Netherlands Cancer Institute United States	Quantitative background parenchymal enhancement, measured on contrast-enhanced mammogram, as a novel marker of breast cancer risk	7R37CA284134-02		Claire Zhu, Ph.D.
Webster, Nicholas J	Veterans Medical Research Fdn/San Diego United States	The Effect of Time-Restricted Eating on the Efficiency of Chemo- and Hormonal-Therapy in Breast Cancer	5R21CA288777-02		Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Webster, Nicholas J	University Of California, San Diego United States	Time-restricted feeding and breast cancer	5R01CA196853-08	PA-20-185 (Parent R01 Clinical Trial Not Allowed)	Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Wei, Lei	Roswell Park Cancer Institute Corp United States	Advancing skin cancer prevention by tackling UV-induced clonogenic mutations	5R01CA255242-05		Wendy Wang, Ph.D., M.Sc.
Welsh, Joellen	State University Of New York At Albany United States	Vitamin K: Body Pools and Function in Breast Cancer	5R01CA258231-05	PA-20-185 (Parent R01 Clinical Trial Not Allowed)	Young Kim, Ph.D.
Wheeler, Stephanie Brooke	Univ Of North Carolina Chapel Hill United States	Optimizing Endocrine Therapy Adherence through Motivational Interviewing and Text Interventions	5R01CA237357-05
Whitman, Eric	Atlantic Health System, Inc. United States	The Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC CORP)	5UG1CA239772-06		Vanessa A. White, M.P.H.
Wilkin, Timothy J.	University Of California, San Diego United States	Partnership for advancing cervical cancer prevention in women living with HIV (CASCADE - Research Hub)	7UG1CA275414-04		Maria Silvina Frech, Ph.D., M.S.
Williams, Paige L	Harvard School Of Public Health United States	Pediatric HIV/AIDS Cohort Study (PHACS) 2020	3P01HD103133-05S1		Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Wilson, William A	Columbus Community Clinical Oncology Prg United States	Columbus NCORP RFA-CA-18-016	5UG1CA189954-11		Vanessa A. White, M.P.H.
Wilson, Michael R	Wayne State University United States	Does obesity influence protein quality control in endometrial cancer?	5R00CA252152-05		Amit Kumar, Ph.D.
Winer, Rachel L.	University Of Washington United States	The CASCADE CLIMB: Cervical cancer prevention in women Living with HIV research Mobilization Base	5UG1CA275402-03		Maria Silvina Frech, Ph.D., M.S.
Winger, Joseph Giles	Duke University United States	Engage: A Randomized Controlled Trial Testing the Efficacy of a Telehealth-Delivered Psychosocial Intervention to Decrease Symptom Interference in Patients with Advanced Cancer	1R01CA291768-01		Brennan Streck, Ph.D., RN, M.P.H.
Winters-Stone, Kerri M	Oregon Health & Science University United States	Patterns and predictors of symptoms, falls, and functioning across treatment and recovery in patients treated with neurotoxic chemotherapy for cancer	5R01CA248059-05		Goli Samimi, Ph.D., M.P.H.
Wolpin, Brian Matthew	Dana-Farber Cancer Inst United States	Altered metabolism and machine learning for pancreatic cancer early detection	5U01CA210171-08		Matthew Young, Ph.D.
Wong, David T	University Of California Los Angeles United States	Characterizing longitudinal dynamics of indeterminate pulmonary nodules using semantic, radiomic, and deep features	3U01CA233370-07S1
Wright, Alexi A	Dana-Farber Cancer Inst United States	Randomized trial of REVITALIZE: A telehealth intervention to reduce fatigue interference among adults with advanced ovarian cancer on PARP inhibitors	1R01CA289547-01		Goli Samimi, Ph.D., M.P.H.
Wu, Yun	State University Of New York At Buffalo United States	Lung Cancer Early Detection and Immunotherapy Response Prediction and Monitoring with an Exo-PROS Liquid Biopsy Assay	5R01CA272827-03		Christos Patriotis, Ph.D., M.Sc.
Wu, Bechien	Kaiser Foundation Research Institute United States	PRedictiOn Algorithms for the DeTECTion of Early Stage Pancreatic Cancer (PRO-TECT)	5R01CA230442-05		Matthew Young, Ph.D.
Wu, Yun	State University Of New York At Buffalo United States	Exosomal Thomsen-Friedenreich glycoantigen as a new biomarker for lung cancer screening and early detection	5R21CA267934-02	PAR-20-292 (R21 Clinical Trial Optional)	Matthew Young, Ph.D.
Xiao, Yi	University Of Tx Md Anderson Can Ctr United States	Exploring new strategy for breast cancer immunoprevention by targeting histamine receptor H1	5R21CA286318-02		Anda Vlad, M.D., Ph.D.
Xing, Chengguo	University Of Florida United States	Quantifying NNK metabolites to facilitate Kava lung cancer prevention clinical translation	5R03CA273467-02		Gabriela Riscuta, M.D., CNS
Xu, Chunhui	Emory University United States	High-throughput assessment of chemotherapy-induced cardiotoxicity in 3D human cardiomyocytes	1R21CA285254-01A1		Eileen Dimond, R.N., M.S.
Xu, Xiangxi Mike	University Of Miami School Of Medicine United States	Countering microtubule stabilization within hair follicles in ovarian cancer chemotherapy	5R01CA286527-02		Rachel Altshuler, Ph.D.
Yaddanapudi, Kavitha	University Of Louisville United States	A Stem Cell Based Exosomal Vaccine for the Prevention of Cancer	5R21CA277314-02
Yaghjyan, Lusine	University Of Florida United States	Stromal contributions to breast carcinogenesis	5R01CA277817-02		Christos Patriotis, Ph.D., M.Sc.
Yang, Qing	University Of Texas Med Br Galveston United States	The role of acute excitation of sensory neurons in the development of paclitaxel-induced peripheral neuropathy	1R01CA273001-01A1		Rachel Altshuler, Ph.D.
Yang, Wan	Columbia University Health Sciences United States	UNCOVER: underlying novel causes of onset of very early cancer research	5R01CA257971-04
Yeh, Jennifer M.	Boston Children'S Hospital United States	Genetic testing to guide pediatric cancer care and follow up: using anthracycline-associated cardiac toxicity as a model for the future	5R01CA227576-05		Eileen Dimond, R.N., M.S.
Yeh, Jennifer M.	Boston Children'S Hospital United States	Can risk-reducing medications improve breast cancer prevention in childhood and adolescent cancer survivors? Comparative modeling to inform care	5R01CA261874-03		Eileen Dimond, R.N., M.S.
Yendamuri, Saikrishna	Roswell Park Cancer Institute Corp United States	Metformin for chemoprevention of lung cancer in obese subjects at high risk	3R01CA255515-04S1		Eva Szabo, M.D.
Yilmaz, Omer	Massachusetts Institute Of Technology United States	PROSPECT - Stem cell models	1OT2CA297570-01		Asad Umar, D.V.M., Ph.D.
Yost, Kathleen J	Corewell Health United States	Cancer Research Consortium of West Michigan (CRCWM)	5UG1CA189860-11		Vanessa A. White, M.P.H.
You, Ming	Methodist Hospital Research Institute United States	Chemoprevention of lung cancer by targeting lonidamine to mitochondria	5R01CA232433-05		John Clifford, Ph.D.
You, Ming	Methodist Hospital Research Institute United States	Targeting phenethyl isothiocyanate to mitochondria in lung carcinogenesis	5R01CA280746-02		John Clifford, Ph.D.
Young, Steven L	Duke University United States	Collaborative Center to Develop Improved Diagnostic and Therapeutic Approaches to Endometriosis	5P01HD106485-04		Goli Samimi, Ph.D., M.P.H.
Yu, Anthony Francis	Sloan-Kettering Inst Can Research United States	Intensive Blood Pressure Control During Cardiotoxic Breast Cancer Treatment (PROTECT) Trial	5R37CA273923-03	PAR-21-329 (R01 Clinical Trial Optional)	Eileen Dimond, R.N., M.S.
Yu, Dihua	University Of Tx Md Anderson Can Ctr United States	Exploring novel strategies for immunoprevention of estrogen receptor negative breast cancer	5R01CA270010-03	PA-20-185 (Parent R01 Clinical Trial Not Allowed)	Marjorie Perloff, M.D.
Yu, Danxia	Vanderbilt University Medical Center United States	Gut microbiota-related mechanisms that impact colorectal cancer risk after bariatric surgery	5R01CA275864-02		Edward Sauter, M.D., Ph.D.
Yuan, Ying	University Of Tx Md Anderson Can Ctr United States	Coordinating and Data Management Center for Translational and Basic Science Research in Early Lesions	5U24CA274212-03	RFA-CA-21-055 (U24 Clinical Trial Not Allowed)	Christos Patriotis, Ph.D., M.Sc.
Yun, Jihye	University Of Tx Md Anderson Can Ctr United States	Impact of sugary drinks on gut microbiota and development of young-onset colorectal cancer	7R21CA258134-02		Gabriela Riscuta, M.D., CNS
Zarrinpar, Amir	University Of California, San Diego United States	Engineering Native E. coli to Detect, Report, and Treat Colorectal Cancer	5U01CA265719-04		Guillermo Marquez, Ph.D.
Zeng, Melody Yue	Weill Medical Coll Of Cornell Univ United States	Dissecting the interplay between immunoglobulin G and the gut microbiome in cancer progression and metastasis	5R21CA270998-02		Young Kim, Ph.D.
Zhang, Zhen	Johns Hopkins University United States	A multidisciplinary BCC for ovarian cancer early detection: translating discoveries to clinical use with a by-design approach	5U2CCA271891-03		Christos Patriotis, Ph.D., M.Sc.
Zhao, Hua	University Of Virginia United States	Homologous recombination repair capacity in peripheral blood lymphocytes as a breast cancer risk factor	5U01CA260731-03	PAR-18-913 (U01 Clinical Trial Not Allowed)	Claire Zhu, Ph.D.
Zheng, Yingye	Fred Hutchinson Cancer Center United States	Statistical Methods for Prospective Evaluation of Biomarkers	5R01CA236558-15
Zheng, Yingye	Fred Hutchinson Cancer Center United States	The Early Detection Research Network: Data Management and Coordinating Center	5U24CA086368-24		Guillermo Marquez, Ph.D.
Zheng, Yingye	Fred Hutchinson Cancer Center United States	Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit	5U24CA288185-02		Guillermo Marquez, Ph.D.
Zhou, Xianghong Jasmine	University Of California Los Angeles United States	The UCLA Center in Early Detection of Liver Cancer	5U01CA230705-07		Sidney Fu, M.D.
Zhou, Xianghong Jasmine	University Of California Los Angeles United States	Multi-cancer early detection using cell-free DNA methylome analysis	5U01CA285010-02
Zhou, Xianghong Jasmine	University Of California Los Angeles United States	Detecting and locating cancer for patients with CT-detected lung nodules	5R01CA264864-03		Guillermo Marquez, Ph.D.
Zhu, Yazhen	University Of California Los Angeles United States	Click Chemistry-Mediated Surface Protein Assay for Quantifying Subpopulations of Hepatocellular Carcinoma-associated Extracellular Vesicles	5R01CA277530-02		Matthew Young, Ph.D.
Zhu, Yazhen	University Of California Los Angeles United States	Extracellular Vesicle-Based Digital Scoring Assay for Detecting Early-stage Hepatocellular Carcinoma	5R01CA255727-05		Matthew Young, Ph.D.
Zhu, Yong	Univ Of Arkansas For Med Scis United States	Explore piRNAs as a novel group of biomarkers for ovarian cancer early detection	1R21CA277412-01A1		Christos Patriotis, Ph.D., M.Sc.
Zi, Xiaolin	University Of California-Irvine United States	Nautral products for targeting Skp2 in cancer interception	5UG3CA290368-02		Altaf Mohammed, Ph.D.